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ABSTRACT 
The number of diabetics, obese individuals and other patients carrying other lifestyle diseases 
is increasing worldwide. At the same time the population is ageing. These patients all suffer 
from poor blood circulation, which often gives rise to non-healing, or chronic, wounds. Thus, 
the number of chronic wounds is also increasing at a fast pace. Such wounds often carry 
infection since the wound environment is favorable for bacteria. The wounds cause pain, odor 
and can lead to amputation or even death. Hence, the patients are treated with systemic and 
topical antimicrobial substances, e.g. antibiotics. However, the overexposure and misuse of 
such drugs has created another issue worldwide: bacterial resistance. There are already some 
infections that are difficult to treat due to the rapid development of bacterial resistance and 
fewer working drugs. 
Our work has focused on a release platform that can administer drugs only when a wound 
shows signs of infection. By sensing the type of infection at hand, the release system should 
break down and expose a suitable antimicrobial substance to the bacteria. Such a release 
system would not only combat the infection but also decrease the risk of bacterial resistance 
and other side effects on the patient, since it would be administered locally and only when it is 
needed. 
Two bacteria were chosen as targets, Staphylococcus aureus and Pseudomonas aeruginosa, 
which often are pathogenic in chronic wounds. Both bacteria exude very substrate specific 
proteases, i.e. V8 and Protease IV, respectively. Hence, nanofilms corresponding to each 
protease were assembled via the layer-by-layer route. V8 readily degrades peptide bonds 
involving poly-L-glutamic acid (PLGA), which also was the main component in the release 
system against S. aureus, while Protease IV degrades bonds involving poly-L-lysine, which 
hence was used as component in the release system against P. aeruginosa. The nanofilms 
were found not to be degraded by normal human enzymes; however, each bacterial protease 
ruptured their respective film if they reached a concentration similar to the concentration 
found in a chronic wound. Consequently, the drug was released or exposed only when in 
contact with the bacterial enzymes. Such release systems could be used to fight infection 
while avoiding bacterial resistance and misuse of antimicrobials.  
Keywords: Layer-by-layer, multilayer, enzymatic degradation, triggered release, controlled 
release, nanofilm, infection 
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Bacteria-responsive 
materials for drug 
delivery 
1 INTRODUCTION 
Diabetes, obesity and cardiovascular 
disease are factors that often lead to the 
development of chronic wounds. Even 
though millions of people suffer from 
chronic wounds there is not a 
straightforward answer to why the healing 
process is disturbed, but poor blood 
circulation is almost always a common 
factor. Complications connected to the 
prolonged healing time are not only costly, 
they also create suffering for the patient 
due to increased pain, infection, sepsis, 
amputation and even death. Approximately 
2% of the general population in the US 
suffers from chronic wounds and the 
estimated cost exceeds US$ 50 billion 
(Kuhn 1992, Gordon 2004, Hess 2004, Sen 
2009, Driver 2010). As for the future, the 
prevalence of hard-to-heal wounds will rise 
due to the dramatic increase of metabolic 
disorders in the world. For example, it is 
predicted that approximately 8.3% of all 
adults had diabetes in 2013, i.e. 382 
million people where almost 50% were 
undiagnosed (The international diabetes 
federation). In the year 2035 the number of 
diabetics is estimated to 592 millions, 
which is an astonishing 55% increase from 
2013. A lifestyle change in all types of 
patients is needed to increase blood 
circulation; however, age, pain and the will 
to change at an early stage are factors that 
prevent healing. Thus, the prevention and 
treatment of wounds becomes a necessary 
component for the management of the 
underlying disease. This work describes 
bacteria-responsive drug delivery to 
chronic wounds that carry infection. 
1.1 Background 
1.1.1 Chronic wounds 
Patients with diabetic foot ulcers (DFU), 
venous leg ulcers (VLU) and pressure 
ulcers (PU) all have poor circulation, 
which desensitizes the patient’s 
extremities, e.g. lower leg or foot regions 
for DFU due to microvascular damage 
(Jarrod 2011). This loss of sensation 
makes it difficult to discover the wound as 
it appears, allowing it to spread and stay 
untreated until a large wound has been 
established. Daily checks of the patient’s 
skin are hence crucial. Also, the lack of 
blood supply promotes swelling and 
oedema, particularly in VLU patients due 
to the increased venous pressure. The 
insufficient circulation interrupts the 
patient’s normal healing process and a 
chronic wound appears. Other factors that 
contribute to chronic wounds can be 
neuropathy and difficulty moving. Cancer 
patients with radiation treatment, as well as 
burn victims, are also more prone to 
develop hard-to-heal wounds, often in 
combination with a bacterial infection.  
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The normal wound healing process is 
traditionally divided into three phases: the 
inflammation phase, the proliferative 
phase and the maturation and 
remodeling phase (Velnar 2009, Beanes 
2003), see Figure 1.1. The inflammation 
phase is the first stage and describes the 
wound as it appears and the short time 
after the skin has been broken. Hemostasis 
is initiated by the clotting cascade, i.e. the 
bleeding prevention mechanism called 
coagulation. Different chemical substances 
and growth factors are then released to 
attract inflammatory cells, which not only 
excrete pro-inflammatory cytokines and 
proteases, but also through phagocytosis 
clean the wound from foreign matter such 
as bacteria and dead tissue. Pain develops 
when dead cells excrete certain chemicals, 
which in turn results in release of 
additional pro-inflammatory substances. 
Blood vessels dilate and allows for release 
of wound fluid, thus increasing the 
temperature and the microcirculation in the 
affected area. Simultaneously, a temporary 
extracellular matrix (ECM) is built up as 
support in the healing wound. The duration 
of the inflammatory phase varies; however, 
it lasts until the wound is properly 
“cleaned”. 
Figure 1.1 The three different stages in normal 
wound healing; the complex inflammatory phase in 
(a), (b), (c) and (d), the proliferative phase in (e), 
and the maturation and remodeling phase in (f). 
(Cambridge University Press, 2003) 
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In the proliferative phase several growth 
factors are exuded to allow for tissue to be 
restored. Fibroblasts, endothelial cells and 
other new cells gradually replace the 
inflammatory cells as the healing proceeds. 
At the same time angiogenesis, or develop-
ment of new blood vessels, is triggered. 
Granulation tissue then builds up the 
deeper regions of the wound when 
fibroblasts produce collagen. Also 
epithelialization and contraction of the 
wound will start during the proliferative 
stage, which normally lasts for a few 
weeks depending on the state of the 
wound. The third and last stage, the 
maturing and remodeling phase, involves 
degradation and replacement of the 
temporary ECM built during the 
inflammatory stage. The permanent ECM 
stores collagen which is assembled in 
bundles that make up the scar tissue. 
In a chronic wound the normal healing 
cascade is interrupted. The underlying 
causes for a hard-to-heal wound may 
create an inflammatory environment that 
triggers the production of proteases 
degrading the ECM, hence degrading the 
wound faster than the normal wound 
healing process is able to rebuild the 
wound. Also, DFU and VLU patients may 
have a slow and inadequate production of 
the permanent ECM and the following 
epithelialization, which also will result in 
stalled healing. In other words, the balance 
between degrading and producing 
molecules is of utmost importance for 
wound healing. Due to the disordered 
healing environment, bacterial infection is 
common in chronic wounds (Bowler 1998, 
Landis 2008) and results in a high amount 
of bacterial proteases (Greener 2005). The 
infection and the foreign matter it brings 
stalls the healing further and allows for 
additional degradation of tissue and 
spreading of the wound. Such an infection 
is normally treated with oral antibiotics or 
with gels, creams or wound dressings 
containing antimicrobial substances (Burell 
2003). The above agents are usually 
applied in excess and may generate 
resistant bacteria (Flattau 2008, Percival 
2008) and cause damage on the patient’s 
own cells, hence prolonging the healing 
time and the suffering for the patient and 
increasing the treatment cost. With 
“intelligent” delivery of the active 
substance, i.e. optimized timing and 
dosage, resistant bacteria can be avoided 
and wound healing triggered. 
Within chronic wound care, the primary 
and very important function of a dressing 
is to absorb and retain wound exudate. 
Materials used for this purpose include 
nonwovens, polyurethane foams, 
hydrogels, etc., often with a wound contact 
layer that prevents the absorbing material 
to stick to the wound. A secondary 
function of a wound dressing can be to 
serve as a reservoir for a bioactive 
substance that promotes wound healing 
and which is released into the wound on 
demand. It is obviously of utmost 
importance to treat the underlying cause of 
the chronic wound; however, the 
immediate danger lies in an untreated and 
often infected wound, which could lead to 
severe outcomes such as amputation or 
even death. 
1.1.2 Wounds and treatments 
The earliest wound treatments and 
dressings were natural materials and 
liquids, such as leaves, milk, grease, and 
mixtures of whatever people thought 
would heal a wound. Later on, to protect 
and absorb wound exudate, gauze was 
used. Originally gauze was made of silk, 
but it changed to cotton when it was 
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possible to weave it into loose, net-like 
fabrics for wound care purposes. However, 
even though gauze easily absorbs exudate 
and to some extent protects the wound, it 
also sticks to the wound surface and grows 
into the scab that forms on the healed 
wound. As a result, the wound dressing 
change will damage the skin that already 
has healed and the wound will resurface.  
Since the discovery of moist wound 
healing, there has been a constant flow of 
new dressing materials and wound 
dressings on the market. More complex 
dressings consisting of several layers of 
top, core and wound facing interfaces have 
been invented consisting of e.g. 
nonwovens, polyurethane foams, 
hydrocolloids, hydrogels and soft silicones. 
From the 1990’s until today, other forms of 
treatments were also introduced, such as 
antimicrobial dressings containing silver 
in different forms, collagen dressings, 
negative pressure therapy, bioengineered 
tissue dressings and dressings or skin 
substitutes containing pharmaceuticals, 
growth factors or other active substances. 
The myriad of treatments and dressings 
makes it difficult to choose the product 
that suits the patient best. Initially the 
material needs to absorb and retain 
wound exudate, a property that cannot be 
compromised. Further, the wound contact 
layer should provide moist wound healing, 
and it should prevent the layer from 
sticking to the wound.  
Now, when the chronic wound is given a 
favorable environment for healing, 
additional treatment can be added. Active 
substances to promote healing could be the 
trigger needed for the wound to start the 
stalled healing cascade, especially if the 
wound is infected. An antimicrobial that is 
released only when an infection is present 
would be the ultimate. Human cells should 
preferably not get exposed to such 
substances due to their aggressive nature 
towards all living cells. Also, if only 
released when an active infection is 
present, then the risk of resistance is 
reduced.  
In this research project a hydrophilic 
nonwoven material was chosen as substrate 
for 2D nanofilm formation. This type of 
material is commonly used for wound care, 
either as an absorbing wound material in 
direct contact with the wound, or as part of 
the absorbing core of a complex dressing, 
see Figure 1.2. Additionally, the concept 
was developed into a 3D version including 
microspheres and microcapsules 
containing antimicrobial substances. 
Figure 1.2 A complex dressing and its wound 
exudate path. The dressing absorbs wound exudate 
through the wound contact layer and the liquid is 
then transported to the first core material by 
capillary forces. Retention is an important 
property, which means spreading and holding the 
liquid, and is important between the first and the 
second core material, as well as inside the second 
core. The next step is transport of water vapor 
through the backing film of the wound dressing. 
Nonwoven is a commonly used material in the core 
of such dressings. (Mölnlycke Health Care AB) 
  
Exudate path in a dressing 
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2 OBJECTIVES 
Triggered, controlled or targeted release 
are some of the current “buzz words” when 
it comes to drug delivery. Consequently, 
self-assembled thin films have become an 
increasingly popular research topic in the 
last decade when acting as a barrier in drug 
release. Unnecessary exposure of active 
substances and pharmaceuticals has raised 
problems such as resistant bacteria, 
resistant cancer cells and different side 
effects ranging from light to severe. 
Avoiding treating the whole body, but 
instead targeting the affected areas, as well 
as treating the patient only when the drug 
is needed, would ease the current problem 
of overexposure. Additionally, the thin 
film acts as a barrier and can prolong the 
lifetime of a drug or enhance the 
therapeutic effect, e.g. help bypassing 
cancer cells’ defense systems (Poon 2011). 
Films in the nanometer range, “nanofilms”, 
can be prepared by the layer-by-layer 
(LbL) technique, which involves 
alternating deposition of oppositely 
charged polyelectrolytes onto a surface of 
choice, a procedure pioneered by Decher 
(Decher 1992, Decher 1997).  
In this work, polyelectrolytes were 
assembled using the LbL technique to form 
either 2D or 3D nanofilm structures. The 
2D version was deposited on a tailored 
gold surface resembling a traditional 
nonwoven wound dressing material. The 
3D versions were either microspheres 
assembled via the o/w emulsion pathway 
or microcapsules made through template 
assisted assembly. All versions were made 
with the intention to be degraded by 
bacterial proteases while remaining intact 
in absence of such proteases. Such systems 
could thus carry an antimicrobial drug and 
release the active substance upon a trigger 
exuded by the bacteria. The choice of 
polyelectrolytes acting as shell was hence 
key. As for Staphylococcus aureus and 
Pseudomonas aeruginosa, particularly 
virulent strains, proteases that degrade host 
tissue for nutritional use during infection 
were investigated. Also, the specificity of 
the proteases was considered, since the 
drug release should be directly dependent 
on the amount of bacterial enzymes at the 
infected site, e.g. a chronic wound. S. 
aureus proved to have a glutamic acid-
bond specific endoprotease filling the right 
criteria, and P. aeruginosa a lysine-bond 
specific one. Tuning the release of actives 
to the degree of infection seems not to 
have been described before, although 
antimicrobial LbL films have been 
reported (Shukla 2010). Quartz crystal 
microbalance with dissipation monitoring 
(QCM-D) was used as the main method for 
studying the stepwise 2D nanofilm LbL 
assembly followed by the enzymatic 
degradation at physiological pH. The 
microspheres were studied with a zetasizer 
and confocal laser scanning microscopy 
(CLSM), while UV/vis was used for the 
release studies. As for the microcapsules, a 
zetasizer, CLSM, fluorescence 
microscopy, NMR and antimicrobial tests 
were used when investigating the build-up, 
drug loading and enzymatic degradation. 
This thesis describes the use of currently 
available building stones that are 
assembled for “intelligent” release of drugs 
to infected wounds.  
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3 THEORY 
3.1 Polyelectrolytes 
Polyelectrolytes are polymers with 
ionizable groups, such as carboxylates or 
protonated amines, and are normally easily 
dissolved in water and other polar solvents. 
The polyelectrolyte can either carry a net 
negative or a net positive charge, i.e. be an 
anionic or a cationic polyelectrolyte. If the 
polymer has strongly dissociating groups, 
the charge is not pH dependent. Such 
molecules are called strong 
polyelectrolytes. On the other hand, a weak 
polyelectrolyte has reversible proton 
transfer and hence the charge will change 
with pH (Holmberg 2003, Malmsten 2003). 
Polyelectrolytes may also exhibit a more 
complex structure, either have charges that 
are unevenly distributed over the 
macromolecule or be a polyampholyte that 
carries both negative and positive charges. 
Proteins are examples of polyampholytes 
(Fleer 1993).  
When in solution, the dissociated groups 
are accompanied by counterions of 
opposite charge. These counterions should 
not be mistaken for the ionic strength of 
the solution, which describes the added 
amount of salt, which is an important 
parameter for tuning the solution properties 
of polyelectrolytes (Decher 2003, 
Dobrynin 2005). The immediate proximity 
of counterions increases the osmotic 
pressure of the solution and contributes to 
the polyelectrolytes’ solubility in water 
(Takahashi 1970, Netz 2007, Nagy 2010). 
In a dilute polyelectrolyte solution and at 
low ionic strength, the macromolecule is in 
its most extended form, primarily due to 
intramolecular forces. Each of the charged 
repeating units of the macromolecule 
experiences repulsion and the forces are 
strongest in the center of the molecule 
(Dobrynin 2005). The extended and 
swollen form of the polyelectrolyte 
influences the overlap concentration, 
making it very small. Due to these 
particular properties of polyelectrolytes, 
the viscosity is also often larger than for 
uncharged polymers of similar molecular 
weight and of the same concentration (Netz 
2007). As the ionic strength increases, the 
charged polymeric molecule changes 
conformation into a blob-like, coiled 
structure, see Figure 3.1. This effect is due 
to screening of the charges. Other 
parameters that affect polyelectrolytes are 
pH, temperature, concentration and solvent 
composition (Dubas 1999, Decher 2003, 
Dobrynin 2005). 
 
Figure 3.1 Polyelectrolytes in solution and their 
conformational dependence on ionic strength. With 
increasing salt concentration and at low poly-
electrolyte concentration the polyelectrolyte’s 
charges are increasingly screened, which allows 
the polymer to form a more coil-like structure. 
3.1.1 Multilayer formation 
and layer-by-layer 
Until around 2000 the Langmuir-Blodgett 
(LB) technique was the most common 
method for preparing nanostructured films. 
The technique is based on the transfer of a 
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monolayer formed on a water surface to a 
solid surface (Blodgett 1934, Blodgett 
1937). However, the LB technique has its 
limitations, since it requires very 
hydrophobic molecules, and the films may 
rearrange after and during the transfer to 
the solid surface. The layer-by-layer (LbL) 
film forming technique was pioneered by 
Decher in the early 1990’s (Decher 1992, 
Decher 1997), creating a scientific 
platform for multilayer formation that 
commercially caught up speed ten years 
later. LbL enables simple nanofilm 
assembly and has a wide range of 
(potential) applications.  
LbL deposition belongs to the same 
category as LB, i.e. template assisted 
assembly. However, LbL is a swift 
technique with less uncertain outcome than 
LB. Without significant chemical 
modification, tailored multilayers can be 
assembled from a variety of components 
(Lvov 1994, Sukhorukov 1996). The 
assembly of LbL films relies on an 
overcompensated surface charge when an 
oppositely charged polyelectrolyte is 
deposited onto it, i.e. sequential deposition 
of oppositely charged polyelectrolytes can 
be performed if the surfaces have an excess 
opposite charge. The assembly requires a 
rinsing step before the oppositely charged 
polyelectrolyte can be deposited. This 
procedure can be repeated many times, see 
Figure 3.2. The adsorption of 
polyelectrolytes can be carried out on a 
variety of different surfaces, as long as the 
surface has a charge opposite to that of the 
first polyelectrolyte being deposited 
(Decher 2003). Measuring the zeta-
potential is a way to study the changes in 
surface charge during the stepwise film 
assembly.  
The main prerequisite for film formation is 
solvent accessible surfaces. However, 
tuning the multilayer build-up requires 
control of other parameters, such as salt 
concentration and pH. Other important 
parameters are polyelectrolyte 
concentration, temperature, adsorption 
time, solvent composition, density of 
charged groups, surface roughness, 
surrounding humidity, rinsing time, drying 
time, etc (Decher 2003). 
 
Figure 3.2 Starting with a negatively charged 
surface immersed into a solution of (a) a cationic 
polyelectrolyte is deposited onto the surface, (b). 
After adsorption and reorganization an anionic 
polyelectrolyte is deposited onto the cationic 
surface, (c), and so on. A washing step between 
each polyelectrolyte deposition is required and 
numerous bilayers can be assembled. 
Reproducing the deposition conditions 
enables repeatable results which is 
especially important when handling weak 
polyelectrolytes, since they are far more 
sensitive to their surroundings than strong 
polyelectrolytes.  
The thickness of assembled multilayers is 
directly dependent on the salt 
concentration, which is a straightforward 
way of controlling the thickness of the 
single layer, as well as the final film. The 
charge densities of the surface and of the 
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polyelectrolyte as well as the salt 
concentration affect the adsorption. Strong 
polyelectrolytes normally adsorb in small 
amounts when a low salt concentration is 
used, while increasing the salt 
concentrations leads to thicker layers, see 
Figure 3.3. However, the weaker and more 
sensitive polyelectrolytes have different 
adsorption patterns. A low ionic strength 
often promotes adsorption (Fleer 1993).  
Having the pKa of a weak polyelectrolyte 
in mind, it is possible to govern the 
conformational changes by altering the pH. 
Hence, a coil-like structure can be attained 
and the adsorption pattern will be similar 
to that for strong polyelectrolytes with a 
high ionic strength. Also, the type of 
polyions and the deposition conditions 
affect the film thickness, and as a general 
rule of thumb more layers are needed in a 
solution of low salt concentration to 
generate a multilayer as thick as that 
obtained at higher salt concentration. By 
changing the salt concentration in solution, 
the multilayer thickness can also be 
affected after assembly by rearranging the 
polyions through swelling or de-swelling. 
Film layers placed in a solution with high 
ionic strength often swells, and they de-
swell if placed in a solution without salt. 
This behavior is influenced by the opening 
and closing of salt bridges between the 
oppositely charged polyelectrolyte layers 
and their counterions (Decher 2003). The 
first polyelectrolyte deposition will be 
strongly affected by the substrate charge 
and in order to facilitate the adsorption a 
primer such as PEI (polyethyleneimine) is 
sometimes used, promoting adsorption by 
creating a higher surface charge as the 
surface roughness is increased (Decher 
2003). 
 
Figure 3.3 Adsorption of strong cationic poly-
electrolytes on a negatively charged substrate. 
Counterions and salt ions are not shown in this 
picture. With increasing ionic strength, the added 
ions contribute with a screening effect and the 
macromolecule forms a coil-like structure due to 
the decrease of the electrostatic repulsion between 
the monomer units. Hence the polyelectrolytes with 
lower salt concentration adsorb less and give a 
thinner and less dense film than the structure with 
higher ionic strength. The segments (a), (b) and (c) 
represent the tail, the train, and the loop, 
respectively. 
3.1.2 The Zone model 
The zone model describes the multilayer 
structure in a simplified way during film 
formation, see Figure 3.4. Two areas are 
charged, Zones I and III, while Zone II is 
considered neutral. However, the actual 
multilayer film does not have such precise 
zones, as the polyelectrolytes constituting 
the structure intermingle, hence resulting 
in diffuse interfaces. Zone II is formed 
after Zones I and III, having forwarded an 
increasing charge from Area I to Area III. 
Consequently Zone II increases its 
thickness, while the two other zones 
remain constant as the multilayer grows. 
The polyelectrolyte molecules usually 
settle at the deposition site; nevertheless, 
each polymer chain intertwines with the 
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neighboring chain and creates a successive 
transition between the layers. The 
distribution of polymers in the middle of 
each plane, or the segment concentration 
profile, is determined by the spread of each 
individual polyelectrolyte as well as the 
average of different polyelectrolytes in one 
layer. The average layer thickness can 
simply be calculated by dividing the total 
film thickness with the number of 
deposited layers (Decher 2003). Polymer 
sequence and conditions during multi-layer 
assembly, especially salt concentration, 
dictates each unique layer formation. 
Being charge compensated, the second 
zone can be considered polyzwitterionic 
and should swell when in contact with a 
salt solution. The other two zones, 
particularly Zone III, will behave in an 
opposite way since they normally carry an 
excess charge, which means that they will 
swell in pure water. The surface potential 
is measured in the third Zone. 
 
Figure 3.4 The zone model describes the multilayer 
film formation and structure in a simplified way. 
Zones I and III carry a net excess charge while 
Zone II is considered neutral. As the 
polyelectrolytes are deposited, Zone II is the only 
area that grows and the top and bottom areas stay 
at a constant thickness.  
3.1.3 Ex-situ and in-situ 
studies of multilayer 
films 
Multilayer films can be investigated either 
ex-situ or in-situ. An already assembled 
nanofilm can be studied with e.g. 
ellipsometry, AFM (atomic force 
microscopy) and NMR (nuclear magnetic 
resonance), while the process of 
assembling a film can be studied with e.g. 
QCM or QCM-D (quartz crystal 
microbalance without and with dissipation 
monitoring, respectively), in-situ 
spectroscopic ellipsometry and AFM (in-
situ atomic force microscopy) (Decher 
2003). QCM-D is a powerful tool for 
investigating adsorption kinetics for a 
variety of strong and weak polyelectrolytes 
and is described in detail in Chapter 4.2. 
3.2 Polyelectrolyte nanofilms 
and biomedical 
applications 
Cationic poly-L-lysine (PLL), poly 
allylamine hydrochloride (PAH) and 
anionic poly-L-glutamic acid (PLGA), 
hyaluronic acid (HA) are all weak 
polyelectrolytes that require strict control 
of pH during and after multilayer film 
assembly, but also polypeptide 
concentration, ionic strength, solvent 
composition and adsorption/rinsing time 
play a role. PLL, PLGA and HA are of 
interest for biomedical applications due to 
their biocompatibility and biodegradability 
(Jessel 2003, Nitzan 2001), and while PAH 
is biocompatible but not biodegradable 
(Janeesh 2014). For the application 
described in this thesis, uncontrolled 
release of incorporated actives can be 
avoided by creating a thin barrier of the 
mentioned polyelectrolytes. For instance, a 
stable PLL/PLGA film assembled under 
physiological conditions will be tightly 
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bound.  Under such conditions the layers 
are tightly knit together mostly consisting 
of extended β-sheets (Pilbat 2006). The 
use of PLGA as the terminating layer 
ensures that the film surface facing the 
wound has a negative charge, which should 
minimize unwanted cell adhesion when in 
contact with a wound bed (Richert 2004, 
Gergely 2004). When studying the 
assembly of the PLL/PLGA nanofilm with 
both in-situ and ex-situ techniques, it has 
been shown that the multilayers normally 
have a water content of 60-70% (Halthur 
2004-I, Craig 2014). PLL and PLGA 
polypeptides have previously been studied 
as coatings on implants for release of IL-12 
(Li 2009) and release of cefazolin (Li 
2010), for immobilizing proteins (Halthur 
2006), and for tissue engineering matrices 
(Hsieh 2005). HA exists naturally in the 
body where it bears several functions 
(Nitzan 2001). Consequently, the 
polysaccharide has been widely used for 
biomedical applications. The company 
Bohus Biotech focusing on HA explains on 
their webpage that it can be used as 
cosmetic fillers, in facial creams, as a part 
of treatment of osteoarthritis (joint 
disease), and in drops or devices for 
ophthalmologic purposes. Research 
involving HA as component in thin films 
focuses on cell targeting and release of 
active substances (Picart 2001, Szarpak 
2010). PAH is commercially available and 
hence used in many studies as a synthetic 
component in thin films, either as a 
component in a synthetic reference system 
to biodegradable thin films (Marchenko 
2012) or in combination with a 
biodegradable component allowing it to 
rupture or swell for triggered release of 
actives (Palamà 2011, Chung 2002, Wang 
2008). 
3.3 Self-assembled 
monolayers on gold 
Self-assembled monolayers (SAMs) are 
ordered structures that spontaneously form 
on a surface. For adsorption onto gold 
surfaces, alkane thiols are often used. The 
molecules have a terminal thiol group that 
readily adsorbs at gold from an ethanol 
solution, and the remaining part of the 
molecule can carry different functional 
groups depending on the application, see 
Figure 3.5. Sometimes monolayers are 
built up from a mixture of different alkane 
thiols. It has been reported that the ratio of 
two different alkane thiols in a monolayer 
at the surface need not to be the same as 
the ratio in solution (Oskarsson 2006). The 
composition of the monolayer reflects the 
relative solubilities of the alkane thiols in 
solution and the interactions between the 
tails. Also, alkane thiols are influenced by 
hydrogen bonding and other attractive 
interactions between polar end groups, 
which in turn affects the apparent 
hydrophilicity and, thus, the wettability 
(Bain 1989-I).  
  
Figure 3.5 Structures of (a) 1-undecane thiol and 
(b) 11-hydroxy-1-undecane thiol. 
3.4 Active substances 
When employing an active substance its 
mode of action needs to be considered. For 
antimicrobials the substance can have 
either a broad-spectrum or a more narrow-
spectrum activity. This distinction is 
generally used for antibiotics; however, the 
antimicrobial effect of most antiseptics can 
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also be divided into a narrower or broader 
activity. For instance, the antiseptic effect 
of silver (Ag
+
) is more pronounced on 
Pseudomonas aeruginosa than on 
Staphylococcus aureus, while for 
polyhexamethylene biguanide (PHMB) the 
antimicrobial effect is more pronounced on 
S. aureus. Quaternary ammonium 
compounds (QACs) are a popular group of 
antiseptics with varying antimicrobial 
effect. The cationic antiseptic is attracted 
to the negatively charged surfaces of a 
bacterial cell’s membrane and can readily 
bind to its surface. The membrane usually 
has surrounding cations, i.e. Na
+
, Mg
2+
 and 
Ca
2+, which are vital for the bacteria’s 
osmoregulation. The Gram-negative 
bacteria’s lipopolysaccharides and the 
Gram-positive bacteria’s teichoic acid 
create their net negative charges (Gilbert 
2005). The membranes’ largest 
constituents are proteins with varying 
functions, e.g. structure or transport. The 
proteins can reach from the surface of the 
cell wall to the core of the cell, or be 
situated at a specific site on the surface of 
the cell membrane. The proteins are 
enclosed in a hydrophobic phospholipid 
bilayer with specific phospholipids as 
neighboring molecules to a specific 
protein.  
Targeting the anionic bacterial cell 
membrane, many QACs are not very 
specific in their actions. Also, the QACs 
need to reach a particular chain length for 
optimal antimicrobial activity for both 
Gram-negative and Gram–positive bacteria 
(Gilbert 2005). The concentration of the 
active substance in QAC containing 
products is usually between 100-1000 
times higher than the minimum inhibitory 
concentration (MIC), which is a 
contributing factor to why resistance does 
not seem to develop.  
A cationic antimicrobial’s most important 
feature is its charge, but it also needs a 
hydrophobic part, which can interact and 
disturb the phospholipid cell membrane. 
As a result, the interaction between the 
QAC and the membrane leads to leakage 
of counterions and consequently to 
disturbance of the osmoregulation in the 
cell. The holes may also lead to leakage of 
other intracellular components. The net 
result is that the cell dies. The quaternary 
ammonium compounds used in this thesis 
work are a betaine ester (tetradecyl 
betainate) and poly(hexamethylene 
biguanide). 
Antibiotic substances are usually more 
specific in killing bacteria. For instance, 
the antibiotic used in this work, 
Vancomycin, inhibits the cell wall 
synthesis in Gram-positive bacteria, which 
eventually leads to bacterial death (Rynolds 
1989). By having one single target, the 
bacteria can (and often will) adapt to the 
situation and develop resistance to a 
specific drug. Hence, it is of importance to 
control the administration of antibiotics 
and only use the drug when it is needed. 
3.4.1 Betaine ester 
Amphiphilic betaine esters, such as 
tetradecyl betainate, contain one 
hydrophilic and one hydrophobic moiety, 
where the betaine part originates from 
choline through natural metabolic 
oxidation. Hence, betaine contains a 
quaternary nitrogen in its structure. By 
esterification of betaine with a fatty 
alcohol, a betaine ester is formed. Betaine 
esters are extremely sensitive towards 
alkaline hydrolysis and they easily degrade 
when in contact with water with a pH 
slightly above neutral, generating betaine 
and a fatty alcohol, see Figure 3.6, both of 
which have low toxicity towards 
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mammalian cells. The reason for the very 
rapid alkaline hydrolysis of betaine esters 
is that the ester bond is unusually 
electrophilic and thus susceptible to attack 
by nucleophiles. The carbonyl carbon of 
the ester bond has a pronounced electron 
deficiency because of the electron-
withdrawing effect of the adjacent 
quaternary ammonium group (Thompson 
1989). The hydrolysis is strongly affected 
by pH and the degradation is faster at 
higher pH. For example, tetradecyl 
betainate (which is used in this thesis 
work) was hydrolyzed to 10 % at pH 6 
after 18 hours, to 50 % at pH 7 after 8 
hours, and to 90 % at pH 9 after 10 
minutes (Lindstedt 1990, Ahlström 1999-I).  
Binding of the betaine ester to the cell 
membrane is the first step of the 
bactericidal effect. However, if the pH is 
low, the bacterial membrane’s net charge 
will decrease, which in turn results in less 
binding of the positively charged betaine 
ester to the membrane. 
 
Figure 3.6 Hydrolysis of betaine ester with a chain 
length of 14 carbons. 
The betaine ester’s stability is also 
dependent on the temperature, with the rate 
of hydrolysis increasing with increasing 
temperature. The salt concentration also 
plays a role for the stability, with a 
decrease in hydrolysis rate with increasing 
salinity (Lindstedt 1990). The length of the 
alkyl chain determines the antimicrobial 
efficacy. Alkyl chains of the same length 
as that of the phospholipids in the cell 
membrane seem to have better killing 
effect than shorter ones. This would 
indicate that betaine esters of 16 and 18 
carbons in the alkyl chain would be more 
efficient than the 14 carbon species used in 
this thesis work. However, the aqueous 
solubility of the betaine ester is also a 
parameter to consider. Long chain betaine 
esters are very insoluble in water and can 
therefore not be used in the concentration 
needed for sufficient antimicrobial effect 
(Ahlström 1999-II, Ahlström 1999-III). 
Considering both the strength of 
interaction with the membrane, which 
favors longer chain betaine esters, and 
solubility aspects, which favors shorter 
chain betaine esters, it seems that a betaine 
ester with 14 carbons in the hydrophobic 
tail is optimal for the purpose of this work. 
3.4.2 Poly(hexamethylene 
biguanide) 
Poly(hexamethylene biguanide) or PHMB 
is a bactericide used in swimming pools, 
contact lenses, cosmetics, cleanser in food 
handling, wound cleanser, as preservative 
of plasticized PVC, etc (Gilbert 2005, 
Kaehn 2010), see Figure 3.7. Being a 
quaternary ammonium compound, PHMB 
interacts with the negatively charged 
surface of bacterial cell membranes. 
PHMB has a broader antimicrobial 
spectrum than most other QACs. The MIC 
value for PHMB against Staphylococcus 
aureus is low compared to other QACs 
(about 1 mg/L), and so is its MIC against 
Pseudomonas aeruginosa (100 mg/liter) 
(Paulus 2004). Additionally, PHMB has 
low cytotoxicity; hence, at the working 
concentrations it seems not to affect human 
cells to the extent that other antiseptics 
often do (Kramer 2004). These two 
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properties, low MIC and low cytotoxicity, 
makes PHMB attractive for use as a single 
antimicrobial in a wound dressing. Similar 
to other QACs, PHMB’s 
 
 
 
Figure 3.7 Poly(hexamethylene biguanide) 
(PHMB). The best bactericidal effect is normally  
obtained with a value of n around 12. 
 
antimicrobial efficacy is dependent on the 
length of the alkyl chain. PHMB is an 
oligomer and it has been found that 
oligomers of more than ten repetitive units 
have a stronger antimicrobial efficacy than 
shorter ones (Broxton 1983). PHMB 
initially binds to single phospholipid sites 
on the bacterial cell membrane where 
maximum anionic charges are found. As 
the surrounding ions are dislodged from 
the cell surface, the attached antimicrobial 
polymers create clusters at the adsorption 
sites. Consequently, the PHMB domains 
transform the homogeneous phospholipid 
surface to a heterogeneous surface 
(Broxton 1984-I, Broxton 1984-II, Broxton 
1984-III, Ikeda 1984). This transformation 
is detrimental to the cell wall functions, 
and leakage of surrounding cations is 
normally followed by leakage of 
increasingly larger molecules. As a 
conclusion, PHMB does not only have the 
same effective antimicrobial activity as 
other QACs, but by transforming the 
bacterial cell surface in a specific way 
makes it a very interesting biocide. As for 
resistance, PHMB does not show any 
evidence of resistance when used at 
appropriate concentrations (Gilbert 2005).  
3.4.3 Vancomycin 
Vancomycin is a glycopeptide antibiotic 
substance, which has been frequently used 
against Gram-positive bacterial infections 
for over fifty years (Levine 2006), see 
Figure 3.8. 
 
 
Figure 3.8 Vancomycin hydrochloride. 
By inhibiting the cell wall peptidoglycan 
synthesis Vancomycin kills for instance S. 
aureus (Reynolds 1989), while Gram-
negative species usually are left 
unaffected. However, Vancomycin 
anchored onto carriers has been shown to 
interact with P. aeruginosa cell membranes 
and enhance the antimicrobial action (Kell 
2008, Gu 2003, Gurunathan 2014). The 
antibiotic substance is administered either 
as a solution (intravenously), orally or as a 
cream. Since Vancomycin has been used 
for decades, it is of little surprise that some 
Gram-positive species have developed 
drug resistance. Despite the resistance 
issues, Vancomycin is still used until new 
substances are cleared by the authorities. 
The use of Vancomycin in this project was 
as a model antibiotic, due to its solubility 
in water and the availability of fluorescent 
equivalents. 
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3.5 Wound infection and 
enzymes 
Chronic wounds almost always have an 
underlying cause, e.g. diabetes. 
Consequently, poor blood circulation 
contributes to stalled healing together with 
other factors that disturb the normal wound 
healing cascade. Additionally, having an 
unfavorable environment for healing 
increases the risk for infection, allowing 
bacteria to contaminate, colonize and 
spread infection. All of the above 
conditions prevent the wound from 
healing, but the infection needs to be 
clinically addressed before any other 
treatment is considered.  
Various bacteria normally colonize human 
skin, e.g. Staphylococcus epidermidis, 
Corynebacteria, Staphylococcus aureus, 
etc. The human microbiome benefits the 
host by for instance competing against 
pathogens and triggering the host immune 
system (Todar 2012). Consequently, when 
skin is compromised and a wound appears, 
bacteria of different types will also be 
present. A few of the bacteria in the normal 
human skin microbiome are pathogenic in 
deeper tissue and blood and can hence 
cause an infection. Staphylococcus aureus 
is an example of such a bacterium. Other 
pathogenic bacteria that normally do not 
exist on intact skin are also found in 
wounds and may cause difficult infections, 
for instance Clostridium perfringes, 
Streptococcus pyregenes and Pseudomonas 
aeruginosa (Kirketorp-Møller 2011). 
Three main stages portray the 
microbiology of the wound in a simplified 
way. Contamination is the first phase and 
relates to the fact that bacteria are only 
present in the wound. Colonization is the 
second stage, where bacteria present in the 
wound are multiplying; however, during 
colonization no visual damage of the tissue 
is noticed. In some cases though, during 
the so called critical colonization stage, 
other unfavorable effects of wound healing 
can be seen. The third phase is infection, 
which is the stage when tissue damage by 
pathogens is clearly seen (Edwards 2004). 
The microbiological load on a chronic 
wound can be either superficial or found in 
deeper tissue, situations that obviously 
need different diagnostic tools, i.e. 
common swabs or biopsies. The swab can 
give information about shallow bacteria 
infecting a large area, while the biopsy 
gives information about bacteria embedded 
deeper into the wound tissue. There are 
both advantages and disadvantages with 
these techniques; however, the most 
commonly used and cheapest method for 
detection of infection today is the swab.  
For protection against their host, many 
bacteria create a biofilm that hinders 
phagocytosis by human leucocytes (Leid 
2005). Additionally, extracellular 
polysaccharides in biofilms also protect the 
colony of invaders as well as production of 
several different substances, such as toxins 
and proteases, which weakens the host’s 
response to the infection (Vuong 2004, 
Greener 2005, Jensen 2010). Chronic 
wounds exhibit increased levels of 
proinflammatory cytokines and matrix 
metalloproteinases (MMPs), which seem to 
be produced in response to biofilm content, 
i.e. polysaccharides, peptidoglycans, etc. 
Bjarnsholt et al. describes the properties of 
a chronic wound as dependent on the 
proximity of the bacterial biofilm 
(Bjarnsholt 2007), while biofilms are less 
common in acute wounds. Systemic 
antibiotics have often had far less success 
in treating bacteria in biofilm than as free 
specimens, and may be up to 1000 times 
less effective. Biofilms may therefore 
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promote development of resistance. 
However, local treatment with some 
antimicrobial substances is more effective 
at penetrating biofilms and killing bacteria 
(Alandejani 2009, Daeschlein 2013, 
Brackman 2013), particularly in 
combination with wound debridement 
(Wolcott 2010). This supports the concept 
of a “smart” drug delivery material that 
releases an active substance if the wound 
shows signs of infection. 
The chronic wound environment 
contributes to an increase in pH compared 
to an acute wound, i.e. the pH ends up 
around 7-8, which is favorable for the 
activity of many of the bacteria’s proteases 
(Dissemond 2003). In some cases the pH 
well exceeds 8. Hence, the amount of 
bacterial proteases is high in infected 
chronic wounds (Bowler 1998, Landis 
2008) and contributes to delayed healing. 
The proteases are exuded as a smokescreen 
to dim the presence of bacteria from the 
human immune system, which is done by 
degrading cytokines, antibodies, 
antimicrobial peptides, host tissue, etc.  
3.5.1 Staphylococcus auerus 
and glutamyl 
endopeptidase 
Staphylococcus aureus is a bacterium 
present on normal skin flora. As a 
consequence, the bacteria can contaminate 
broken skin if a lesion or wound is present. 
The bacterium is normally not a problem; 
however, if the patient has an underlying 
cause for delayed healing or if some strains 
such as MRSA (meticillin resistant 
Stapylococcus aureus) contaminate the 
wound, severe infections may occur. The 
bacterium is Gram-positive and belongs to 
the facultatively anaerobic family of 
Staphylococcaceae. S. aureus is shaped as 
spheres with a diameter of approximately 1 
μm and forms clusters as it grows (Todar 
2012). As a mechanism to stay unnoticed 
by the human immune system, the bacteria 
excrete several virulence factors, e.g. 
toxins and enzymes. Other exoproteases, 
such as glutamyl endopeptidase, or V8, 
contributes indirectly to virulence. By 
exuding V8, host tissue is degraded into 
low molecular weight molecules, which act 
as nutrients for the bacterium. As the 
bacteria grow stronger and multiply with 
the help of proteolytic enzymes, V8 also 
inactivates bacterial host responses, thus 
also facilitating bacterial colonization and 
infection (Honeyman 2002). Since chronic 
wounds have an elevated pH and since the 
activity of the enzyme is at its peak at pH 
8, the wound environment is highly 
favorable for V8 proteases.  
Glutamyl endopeptidase is an extracellular 
endopeptidase, which means that it cleaves 
bonds within a molecule, in this case 
peptide bonds solely on the carbonyl side 
of glutamate (Glu) and aspartate (Asp) 
residues. The cleavage next to Glu is 1000 
fold faster than that next to Asp (Sorensen 
1991). Due to the protease’s specificity it 
is used for selective cleavage of proteins 
for peptide mapping. It belongs to the 
family of glutamyl endopeptidase I and is a 
serine protease. However, V8, with its 336 
amino acids, has few analogs and it has 
only slight sequence identity with other 
serine proteases. For instance, the sequence 
identity with bovine trypsin is only 13 % 
and with its homologue glutamyl 
endopeptidase from Staphylococcus 
epidermidis 59 % (Ohara-Nemoto 2002, 
Prasad 2004, Nemoto 2008). It is also 
found that its specificity depends on the N-
terminus, which is very uncommon among 
proteases. V8 carries a net negative charge; 
however, the positively charged N-
terminus seems to have a large impact on 
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the enzyme’s activity (Prasad 2004, Ono 
2010). Certain buffers can inhibit the 
enzyme; however, it does not affect the 
protease’s specificity (Sorensen 1991). All 
properties of V8 contribute to its success to 
impair host tissue and inactivate host 
responses. Its substrate specificity is taken 
advantage of in this thesis work for 
designing a release system for 
antimicrobials.  
3.5.2 Pseudomonas 
aeruginosa and 
Protease IV 
Pseudomonas aeruginosa is a Gram-
negative bacterium with opportunistic 
tendencies. Hosts with compromised health 
are hence more vulnerable against the 
pathogenic strains causing infection at 
several (host) sites, e.g. in soft tissue, bone, 
cartilage, lungs, etc. However, P. 
aeruginosa is foremost a nosocomial 
pathogen (Todar 2012). The bacterium has 
a rod-like structure and belongs to the 
family of Pseudomonadacea, which often 
is found in soil and water. Like S. aureus, 
aerobic P. aeruginosa possesses facultative 
behavior, and is even called a facultative 
anaerobe by some, due to its ability to 
survive in environments with little or no 
oxygen. Generally, the use of oxygen is 
exchanged for the use of NO3, enabling it 
to multiply despite harsh surroundings. 
This fascinating bacterium is famous for 
moving exceptionally fast, its ability to 
grow even in distilled water, being tolerant 
to many antimicrobial substances, to high 
or low temperatures and biofilm formation. 
Similar to S. aureus, P. aeruginosa exudes 
many different chemicals as protection. 
We have focused on the protease called 
Protease IV, which can be expressed in 
Escherichia coli and is then called rLysC. 
The protease is characteristic for the P. 
aeruginosa bacterium and no other bacteria 
in the same or other families carry the 
Protease IV gene. Whether or not, or to 
what extent, most other virulence factors 
are exuded vary on strain and depends on 
the surroundings; however, protease IV 
seems to be the one virulence factor that 
always is exuded (Caballero 2004). In 
other words Protease IV is a very 
important virulence factor for 
Pseudomonas aeruginosa. The serine 
protease is lysine-specific and attacks the 
carboxyl side of lysine bonds in peptides. 
The action leads to tissue damage and also 
strengthens the bacterium’s stronghold by 
degrading host immunoresponse molecules 
(Engel 1998, Wilderman 2001).  
3.5.3 Human neutrophil 
elastase 
Human neutrophil elastase (HNE) is a 
serine protease commonly found in 
wounds. HNE exists in azurophil granules 
in neutrophils, which are successful 
phagocytes that constitute a major part of 
host defense when faced with an infection 
(Pham 2006). HNE has a wide spectrum of 
target substrates and degrades collagen, 
elastin and proteoglycans in the 
extracellular matrix, as well as the outer 
membrane of some bacteria, fungi and 
certain virulence factors. In other words, 
together with HNE inhibitors, this elastase 
participates in the wound healing process. 
However, with a deficiency in inhibitor 
molecules, the tissue will be degraded in 
an uncontrollable manner, which is the 
case with many diseases striking the 
pulmonary airways (Pham 2006). 218 
amino acids form the chymotrypsin-
resembling neutrophil elastase with a net 
positive charge and the enzyme prefers 
hydrophobic substrates (Sinha 1987, Siedle 
2007). Since HNE has a broad spectrum of 
substrate specificity and is commonly 
found in wounds, it was decided to use this 
enzyme for studies of degradation of the 
polypeptide film in a noninfectious 
environment. 
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3.5.4 Trypsin 
Bovine trypsin is a serine protease that 
cleaves a protein at the C-terminal of 
lysine (Lys) and arginine (Arg), but only 
when the preferred amino acid does not 
bind to proline (Pro). Trypsin is specific 
for positively charged substrates 
(Schrøder-Leiros 2004). Being a serine 
protease with some similarity to glutamyl 
endopeptidase (V8) (Prasad 2004), trypsin 
was chosen as reference enzyme in the 2D 
nanofilm degradation studies. 
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4 ANALYTICAL 
TECHNIQUES 
4.1 Contact angle 
Contact angle measurements are widely 
used in research and for quality control of 
surfaces. Wetting of surfaces is related to 
the interfacial tensions between solid, gas 
and liquid, which is described by Young’s 
equation in Equation [1]: 
                               
where σSV, σSL and σLV are the interfacial 
tensions between solid-vapor, solid-liquid 
and liquid-vapor, respectively. A system 
with water as the liquid phase is described 
in Figure 4.1. If the substrate is 
hydrophobic, then θ > 90o, since the 
droplet does not wet the surface. On a 
hydrophilic substrate (θ < 90o), on the 
other hand, the droplet partially or fully 
wets the surface.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 A drop of water on (a) a hydrophobic 
surface and (b) a hydrophilic surface. θ describes 
the angle of the droplet, which if larger than 90o 
indicates a hydrophobic surface, and if less than 
90o, a hydrophilic surface, based on the ability of 
the droplet to wet the surface. 
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4.2 Quartz crystal 
microbalance with 
dissipation monitoring 
Quartz crystal microbalance with 
dissipation monitoring (QCM-D) is a 
powerful technique for studies of 
adsorption and desorption kinetics on 
surfaces. The technique has been 
thoroughly presented in the literature 
(Rodahl 1996, Höök 1998). There is 
considerable interest in the use of the 
technique within the biochemical area 
(Höök 2007).  
Sauerbrey reported in 1959 that the mass 
of molecules deposited on a QCM sensor 
can be measured by studying the decrease 
in frequency (Sauerbrey 1959). The 
frequency and the mass are proportional as 
long as they fulfill three requirements: the 
deposited mass must be substantially 
smaller than the weight of the crystal, the 
molecules must be firmly adsorbed, and 
the adsorbed mass must be evenly 
distributed. Provided that these 
requirements are fulfilled the adsorbed (or 
desorbed) mass,   , changes the 
oscillation frequency,   , of the sensor 
crystal, as described by the Sauerbrey 
equation [2].  
   
    
 
                
In Equation [2], C is the mass sensitivity 
constant, 17.7 ng Hz
-1
 cm
-2
 for a quartz 
sensor with       , and n is the 
overtone number  (n = 1, 3, 5, 7, …), and it 
assumes that the loss of energy of 
oscillation through the film is negligible 
(Vogt 2004). The thickness of the adsorbed 
layer can be estimated using Equation [3], 
where      is the adsorbed layers’ 
effective density. 
     
  
    
               
The substrate used in QCM is a 
piezoelectric quartz sensor crystal, which 
oscillates at its own frequency when 
applied to an electric field. Later studies 
have revealed that for frequency and mass 
to be proportional to variable films 
properties with inevitable variations in 
hydration and hence the damping of the 
deposited matter, the driving voltage 
should be periodically shut off (Rodahl 
1996). By switching off the power it is 
possible to study how the oscillation 
decays exponentially with time (see Figure 
4.2), therefore also including the 
viscoelasticity of a film when calculating 
  , which otherwise would be 
underestimated if using Equation [2] (Höök 
2001-I). The time of decay, , can be 
translated into the dissipation factor,   , 
by measuring the subsequent amplitude 
signal,      (Rodahl 1996, Voinova 1999). 
The amplitude is then fitted numerically, 
which in turn gives the equation shown in 
[4], describing    for the dissipated 
energy during a single dissipation (Rodahl 
1995, Rodahl 1996), 
   
 
   
 
            
         
             
where Edissipation stands for loss in energy 
and Estored is the stored energy of the 
adsorbed layer. For a viscoelastic fluid, the 
Maxwell viscoelastic model is normally 
used when calculating mass (or viscosity) 
for the adsorbed matter. For a viscoelastic 
solid, the Voigt (Voigt-Kelvin) model is 
used (Voinova 1999), see Figure 4.3. 
Viscoelastic films, e.g. adsorbed polymers, 
have a higher dissipation and require a 
more complex mathematical model for 
simulation of the adsorbed mass, e.g. the 
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Voigt based viscoelastic film model. The 
Voigt model describes propagation and 
damping of acoustic waves in a single 
undifferentiated viscoelastic adsorbed film 
in contact with a Newtonian bulk liquid 
(Voinova 1999, Höök 2001-II). 
Adsorbed layers that have frequency 
dependent viscoelastic properties express a 
shear modulus,   , which is related to the 
storage modulus,   , and the loss modulus, 
   . These parameters can in turn be related 
to the elastic shear (elasticity) of the film 
and the film’s viscosity, respectively (Cho 
2007). 
 
As can be seen in Figure 4.4, the frequency 
and the dissipation are dependent on a 
number of film properties. For rigid films 
the Sauerbrey relation is valid; however, 
 
for viscoelastic films the mathematical 
dependence of    and    and the film’s 
mechanical properties have been further 
refined by Voinova et al (Voinova 1999). 
The parameters concerning the quartz 
crystal and the solvent (bulk) are in most 
cases known, but the film parameters need 
to fit the viscoelastic model of choice after 
approximating the film density. 
 
 
 
 
 
Fig. 4.2 Oscillation decaying with time as the 
driving voltage is shut off. 
 
 
 
Figure 4.3 The Maxwell and Voigt viscoelastic 
models include a spring with E as the elastic 
modulus and a dashpot with   as the viscosity. The 
spring describes the applied stress,  , according to 
Hooke’s law, and the stress for the dashpot is 
expressed by Newton’s law,       and   
 
  
  
, where   is the strain. As for the Maxwell 
element, it has a uniform distribution of stress, 
                  , while the Voigt element 
has a uniform distribution of strain,           
        . Consequently, the Maxwell element’s 
strain and the Voigt element’s stress are both 
assumed to be additive and expressed as   
                 and                   , 
respectively. 
 
 
 
Time
ANALYTICAL TECHNIQUES 
22 
 
 
Figure 4.4 Parameters involved in calculating    
and    for a viscolelastic film. As in the literature 
(Voinova 1999), this example describes a film with 
two layers on top of a quartz crystal,  , in a 
Newtonian bulk solvent,  , where the parameters 
are used in a Voigt based model.  is the thickness, 
  the density,   the elastic shear modulus (or   ) 
and   the viscosity. However, the viscous 
penetration depth,  , is also a necessary parameter. 
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4.3 Ellipsometry 
Ellipsometry is an optical technique used 
for studies of the dielectric properties of 
thin films, and it has been thoroughly 
described in the literature (Azzam 1987, 
Tompkins 2005). In brief, the change of 
polarization of light reflected (or 
transmitted) off a sample gives information 
about the thin film, see Figure 4.5. A 
specific sample’s known parameters often 
decide which and how much 
information the ellipsometry 
measurements can give. In two 
situations a direct inversion of the 
ellipsometric angles,   and  , can be 
performed for retrieving the optical 
constants of a studied substrate. The 
first situation is when the only 
unknowns are the optical constants for 
a substrate and the second situation is 
when all is known except the thickness 
(Azzam 1987). However, more often, a 
mathematical model is used to iteratively 
reach the optical constants from the output 
(ellipsometric angles). The latter is done 
with advanced software, where information 
is available for interpretation and modeling 
of data, e.g. calculation of film thickness. 
When studying the thickness of a film, the 
angle of incidence is decided after 
measurements along the normal of the 
sample. A sweep over a range of 
wavelengths is also performed to find the 
wavelength suitable for the specific 
substrate. For studies of the sample’s 
anisotropy, the substrates are rotated and 
measured again. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Schematic description of spectroscopic 
ellipsometry. (www.azom.com) 
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5 EXPERIMENTAL 
METHODS 
For specific concentrations and other 
details, please see the Papers in the end of 
this work. 
5.1 Polyelectrolyte solutions, 
enzyme solutions and 
crosslinking 
5.1.1 Preparation of 
polyelectrolyte solutions 
The polyelectrolytes used were poly-L-
lysine hydrobromide (PLL) (   
      ), poly-L-glutamic acid sodium 
chloride (PLGA) (          ), 
polyallylamine hydrochloride (PAH) 
             and hyaluronic acid 
(HA)                . A Tris-
HCl buffer solution was prepared with 
NaCl (0.1 M for 2D film and 0.15 M for 
the spheres and capsules). For 2D films 
and the films on the o/w emulsion spheres, 
PLL and PLGA were added in an amount 
corresponding to 1 mg ml
-1
. For 3D films 
on template assisted assembly 
microspheres, PLL, PLGA and PAH were 
added at 4 mg ml
-1
, and HA at 5 mg ml
-1
. 
The LbL assembly was prepared at pH 7.4. 
5.1.2 Preparation of enzyme 
solutions 
The bacterial proteases used were V8 
proteinase or glutamyl endopeptidase 
originating from Staphylococcus aureus, 
and  Protease IV, originating from 
Pseudomonas aeruginosa (expressed in E. 
coli, then called rLys-C) Reference 
enzymes were human neutrophil elastase 
(HNE) and trypsin (bovine pancreas). V8 
and Protease IV were diluted to 
concentrations related to an amount related 
to concentrations found in infected wounds 
(Prof. M.D. Artur Schmidtchen, personal 
communication). HNE enzyme solutions 
were diluted to 1:100 or 1:8. Trypsin was 
used at different concentrations ranging 
from 1 wt% (1:100) to equal amounts of 
each (1:1 weight ratio solution). Trypsin 
was only used on the 2D nanofilm.  
5.2 Polyelectrolyte nanofilms 
– 2D 
5.2.1  Gold surfaces and 
characterization of 
nonwoven and tailoring 
of gold sensor surfaces 
The QCM-D sensors were cleaned in an 
UV/Ozone (UVO) chamber combined with 
a treatment using an ammonia-hydrogen 
peroxide mixture. If the sensors were not 
used immediately, they were stored for 
maximum 7 days in ethanol. The 
nonwoven of choice was hydrophilic (θ < 
90
o
) and viscose based, thus cellophane 
was used as a non-absorbing reference 
material. Contact angle measurements 
were used to study the materials’ wetting. 
The tailored gold sensor surface was 
achieved combining 11-hydroxy-1-
undecanethiol with 1-undecanethiol. 
5.2.2 QCM-D: assembly of 
and enzymatic exposure 
to nanofilms 
Tailored gold sensors were either placed in 
a QCM-D D-300 or a QCM-D E4 for 
measurements during LbL assembly and 
during degradation studies. A stable signal 
(     ) was achieved before adding 
either a new polyelectrolyte or buffer 
solution. The stepwise procedure was 
repeated until three bilayers, 
(PLL/PLGA)3, were formed on the SAM 
coated surface. The sensors were either 
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kept wet in the chamber or dried before an 
enzyme was added for studies of 
enzymatic exposure. Analysis of film 
assembly and thickness was performed in 
Q-Tools. 
5.2.3 Ellipsometry 
Ellipsometry measurements were 
performed at ambient temperature using 
wavelengths between 196-2000 nm. The 
ellipsometer operates with an elasto-optic 
modulator. TFCompanion software was 
used for the data analysis. The 
measurements in UV light with a 
deuterium lamp did not give a good fit for 
the current system; however, data analysis 
showed a good fit in visible light between 
400 to 799 nm with the monochromator 
locked at 633 nm. The dual measurements 
were done to avoid possible disturbances 
from the reflective gold surface. The angle 
of incidence was set to 60
o
. The 
ellipsometry samples can be seen in Table 
5.1. Each sample was rotated 90
o
 and then 
180
o
 to study possible sample anisotropy. 
Additional measurements were performed 
when the gold substrates had been plasma 
treated, due to an increased surface 
roughness. 
Sample Modification / Film assembly 
1 Au 
2 Au-SAM 
3 (Au-SAM)-(PLL/PLGA) 
4 (Au-SAM)-(PLL/PLGA)2 
5 (Au-SAM)-(PLL/PLGA)3 
Table 5.1 Samples used in the ellipsometry 
measurements. 
5.3 Polyelectrolyte nanofilms 
– 3D 
5.3.1 o/w emulsion assembly 
of microspheres 
The o/w emulsion was made by using a 
high shear homogenizer and PLGA as 
emulsifier. The oil phase was either 
glyceryl trioctanoate (GTO) or a 1:1 ratio 
mix of GTO and corn oil. The pure GTO 
contained 0.1-1 wt% betaine ester, and the 
oil mix contained 0.01 wt% Nile Red. The 
emulsion was washed three times by 
centrifugation at 10 000 rpm for 1 h. The 
emulsion was added dropwise to a solution 
of a polypeptide of opposite charge to the 
previous layer for LbL adsorption and 
nanofilm build-up. Centrifugation and LbL 
adsorption were repeated until 3 or 5 layers 
were assembled.  
5.3.2 Template assisted 
assembly of 
microcapsules with 
PAH/PLGA shells 
CaCO3 spheres were used as sacrificial 
templates. The porous calcium carbonate 
microspheres had an average size of 3 μm 
(range: 0-10 μm). The spheres were 
suspended at a concentration of 2 wt% 
before ultrasonication. The large 
polycation, PAH, was added before 
washing the solution by centrigugation 
three times (3 500 rpm for 5 min) and then 
the anionic PLGA was added. The LbL 
procedure was repeated until 6 layers were 
created, i.e. (PAH/PLGA)3. The next step 
was to crosslink the nanofilm, see Chapter 
5.3.4. After stabilization of the 
PAH/PLGA shell, a 4 % gluconolactone 
solution with 0.02M MES buffer (see 
Chapter 5.3.4) was added to the capsule 
suspension to carefully dissolve the CaCO3 
templates. The capsules were kept in 
suspension and under stirring. In all steps, 
the ζ-potential was measured.  
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5.3.3 Template assisted 
assembly of 
microcapsules with 
HA/PLL shells 
(HA/PLL)3 nanofilm shells were prepared 
in the same way as the (PAH/PLL)3 shells, 
see Chapter 5.3.2. The only differences 
was that anionic polyelectrolyte was added 
first, HA had a concentration of 5 mg/ml, 
and the centrifugation speed during 
washing needed to be increased to 
approximately 4000 rpm when HA was the 
added layer. 
5.3.4 Crosslinking the films 
To stabilize the films assembled in 
Chapters 5.3.1 to 5.3.3, peptide bonds were 
created by crosslinking. Before 
crosslinking the nanofilms the buffer was 
changed to 2-(N-
morpholino)ethanesulfonic acid sodium 
salt (MES) including NaCl. Crosslinking 
agents were N-(3-dimethylaminopropyl)-
N’-ethylcarbodiim-ide hydrochloride 
(EDC) and N-hydroxysulfosuccinimide 
sodium salt (sulfo-NHS). The 
concentration of EDC was varied between 
25 mM to 200 mM, and the concentration 
of sulfo-NHS between 25 to 50 mM. The 
final washing step was performed with 
centrifugation or dialysis while stirring. 
5.3.5 Loading of 
microcapsules 
Loading was initially performed by adding 
suspended capsules to a probe or drug 
solution (ratio 1:1). A FITC-dextran 
(        ) in MES buffer was used as 
the main model drug. The ionic strength 
was varied between 0.15, 0.5, 0.75 and 
1.25 M. Additional tests were performed 
with other fluorescent model drugs with 
better resemblance to the actual drugs, i.e. 
Rhodamine green (        , cationic) 
comparable to PHMB (           ) 
and Vancomycin BODIPY (   
       , neutral at pH 7) comparable to 
Vancomycin (          ). All loaded 
microcapsules with fluorescent probes 
were investigated in a fluorescence 
microscope with x63 optical zoom. The 
loading of the actual drugs were performed 
in the same way. Removal of excess drug 
was done by either filtration or dialysis 
(while stirring). Also, the loading capacity 
was investigated by studying the remaining 
drug in the surrounding solution. The 
loaded microcapsules were separated from 
the solution using a hydrophilic syringe 
filter, and the surrounding liquid was 
studied in NMR. 
5.3.6 Light microscopy 
Samples were continuously studied in a 
light microscope, where the capsule size 
and their cumulative distribution were 
investigated. 
5.3.7 Zetasizer 
 The surface charge of all microspheres 
and microcapsules were studied after each 
added polyelectrolyte layer (after wash by 
centrifugation) using a Malvern Zetasizer 
Nano Range. 
5.3.8 Environmental SEM 
Environmental scanning electron 
microscopy (ESEM) was initially used to 
study crosslinked microcapsules and 
spheres The ESEM can be used in both 
high and low vacuum mode, as well as in 
the ESEM mode. However, the resolution 
was considered to be too poor for further 
use. Only a few images were received after 
the water had been vaporized at 4.93 Torr 
(657 Pa) and 1 
o
C (5 kV electron beam). 
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5.3.9 SEM 
Samples were either air dried or freeze 
dried on scanning electron microscope 
(SEM) holders. The freeze drying was 
performed at -110 
o
C. All samples were 
sputtered with gold in a 2 x 30 seconds 
cycle.  
5.3.10 Confocal laser 
scanning microscopy 
Microspheres were studied after 
crosslinking in a confocal laser scanning 
microscope (CLSM) using a Plan APO 20x 
magnification 0.7 NA dry air objective 
lens, when the microcapsules or spheres 
had been loaded with a probe.  
5.3.11 NMR 
Quantitative 
1
H NMR spectra were 
acquired using a 400 MHz spectrometer. 
Prepared samples contained 10 % D2O to 
allow for a sufficient lock signal. 
Complementary self-diffusion experiments 
were recorded using a 600 MHz 
spectrometer. All NMR experiments in this 
work were carried out at 25 °C. For the 
spectral analysis and integral calculations, 
the software program MestReNova version 
8.1.2 was used. The loading capacity and 
the spectral determination of PHMB 
concentration was established by 
integration of the NMR signals 
corresponding to the aliphatic hydrogens. 
An aqueous stock solution of 3 wt% 
PHMB was used a reference. Spectral 
determination of Vancomycin 
concentration was established by 
integration of the NMR signals 
corresponding to the methyl hydrogens. An 
aqueous stock solution of 1 mM 
Vancomycin was used a reference. 
5.3.12 Enzymatic degradation 
The crosslinked and enzymatically 
ruptured microcapsules loaded with 4kD 
FITC-dextran were studied in a CLSM 
with objective HCX PL APO CS WATER 
UV with 63 times magnification and a 
numerical aperture of 1.20 with optical 
zoom ×4, ×6.5 and ×20. FITC-dextran was 
excited by a 488 nm argon laser and the 
emitted signal was recorded in the 
wavelength interval 510-550 nm. 
5.3.13 Antimicrobial efficacy 
The pathogenic bacterial strains used for 
efficacy studies of HA/PLL microcapsules 
was ATCC 29260 (Pseudomonas 
aeruginosa, PA 103) and for the 
PAH/PLGA microcapsules ATCC 49775 
(Staphylococcus aureus, strain V8). The 
freeze dried strains were placed in an 
overnight culture of tryptic soy broth 
before dilution in simulated wound fluid 
(SWF) consisting of calf serum and 
peptone water in a ratio of 1:1. The 
working bacterial dilution of 10
6
 cells/mL 
was achieved after adding the 
microcapsule suspension (1:1 ratio) in a 6-
well cell culture plate, thus resulting in a 
final concentration of about 1.5 vol% 
microcapsule suspension. Suspensions 
were mixed and then placed in an 
incubator at 35 ± 2 
o
C and 200 rpm. 
Sampling was performed after mixing the 
suspension with a pipette at 3 and at 24 
hours by adding 0.1 mL of sample to 0.9 
mL of peptone water. The same procedure 
was repeated for the reference (hollow and 
empty microcapsule suspension) and the 
control (bacteria only). Each sample were 
made in three replicates.  
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6 RESULTS AND 
DISCUSSION 
6.1 Characterization of 
nonwoven and tailoring of 
gold sensor surfaces 
Nonwoven is used in wound care either as 
an absorbing material in direct contact with 
the wound or as the core of a complex 
dressing. The sterilized, viscose based 
nonwoven was found to be hydrophilic 
compared to standard nonwoven webs 
made of e.g. polypropylene. Since the 
nonwoven material is absorbing, 
cellophane was used as reference during 
the contact angle measurements. 
Cellophane and nonwoven are both 
regenerated cellulose products and were 
expected to have a similar surface 
chemistry with hydroxyl and methylene 
groups dominating the surface. This was 
also confirmed since the contact angle 
received was 70 ± 2
o 
for both materials. To 
tailor a surface that imitated nonwoven, an 
alkane thiol with a terminal hydroxyl 
group and one with a terminal methyl 
group were mixed in varying ratios in 
ethanol and assembled on QCM gold 
sensors. The ratio of alkane thiols in 
solution and in a self-assembled 
monolayer, SAM, need not be the same 
(Bain 1989-I) since the composition 
reflects the relative solubilities of the 
alkane thiols in solution and the 
interactions between the tails. A 60 to 40 
molar ratio of hydroxyl to methyl 
terminated alkane thiol resulted in a 
contact angle of 72 ± 1
o
, which is in 
accordance with previously reported values 
(Oskarsson 2006). Hence, this composition 
was chosen when creating the model 
surface for the QCM-D and ellipsometry 
measurements. Contact angle results 
obtained for the SAM surfaces were 
repeatable and did not vary with time, 
indicating that the C11 alkane thiol chains 
were long enough to give a stable 
monolayer. It has been claimed that longer 
chains, C16-C24, create more stable layers 
(Everhart 2002); however, it seemed to be 
sufficient with C11 chains in this study. 
Furthermore, PLL/PLGA multilayers built 
on C11 thiols resulted in a repeatable layer 
thickness, whereas the layers built on C16 
thiols had greater variation in thickness. 
The alkane thiols of choice are presented in 
Figure 3.5. 
6.2 PLL/PLGA 2D nanofilm 
assembly on nonwoven, 
cellophane and tailored 
gold surfaces 
6.2.1 Film assembly  
The PLL/PLGA nanofilm was deposited 
onto the hydrophilic nonwoven material to 
investigate the change in contact angle. 
Also, a non-absorbing cellophane sheet 
was used as the reference substrate. Both 
substrates had an initial contact angle of 
approximately 70
o
. The absorbing 
nonwoven was just manageable in the 
previous contact angle measurements, but 
after the crude process of dipping and 
drying, the wetting of the material was too 
fast to be measured. However, the contact 
angle of the treated cellophane substrate 
decreased from 70
o
 to 35
o
. The nanofilm 
was then deposited onto the SAM treated 
gold substrates, which resulted in a slightly 
lower contact angle, approximately 30
o
. 
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6.2.2 PLL/PLGA nanofilm 
assembly studied with QCM-
D 
QCM-D is a gravimetric measurement 
technique, which in this work measures the 
amount of adsorbed polyelectrolytes as 
well as the incorporated solvent in-situ. A 
stable baseline was obtained after the 
buffer injection and after allowing the 
temperature to stabilize at 22.5 
o
C. 
Adsorption of polyelectrolytes on the SAM 
covered gold sensors was monitored at the 
third, fifth and seventh overtone, and the 
variation of frequency was normalized 
versus the overtone. As Figure 6.1 
describes, the cationic PLL adsorbed 
readily to the negatively charged alkane 
thiol surface, hence forming a stable 
foundation for the subsequent layer-by-
layer assembly. The frequency decrease in 
Figure 6.1 indicates an increase in mass. 
Weak polyelectrolytes have a high degree 
of motional freedom, which should be 
observed by an increase in dissipation. 
However, the rapid adsorption of the first 
bilayer only gave small shifts in both 
frequency and dissipation. Such an event 
suggests limited possibilities for 
rearrangements. The measurements on the 
second and third bilayers indicated 
adsorption in loops and tails as well as 
possible penetration into underlying layers, 
as expressed by larger frequency shifts. As 
expected, the dissipation increased for the 
subsequent layers, indicating a three-
dimensional film structure with solvent 
trapped in the film cavities. It was 
important to have control of the so-called 
bulk effect, i.e. the effect of the viscosity 
and the density of the surrounding liquid 
on the multilayer response, see Figure 4.4. 
Hence, the samples were rinsed after each 
polyelectrolyte addition to minimize the 
effect of the bulk. Together with the fact 
that a low polypeptide concentration was 
used during assembly, the bulk effect was 
considered to be small enough to be 
ignored (Knag 2004, Bordes 2010). Also, 
viscosity measurements showed little 
difference between the polyelectrolyte 
solutions and water. 
 
 
Figure 6.1 QCM-D measurements describing the 
shift in frequency in (a) and the dissipation in (b). 
As seen in both graphs, three PLL/PLGA bilayers 
are assembled with buffer rinsing steps (*) between 
each polypeptide addition as a means to minimize 
the bulk effect. Full arrows indicate addition of 
PLL and dashed arrows indicate addition of PLGA.  
 
The viscoelastic character of the film is 
expressed by the lack of overlap in the 
frequency response while     . For 
evaluation of the QCM-D results, a 
viscoelastic Voigt-based model was used 
in Q-Tools, see Figure 4.3 (Voinova 1999). 
This particular model is usually a good 
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representation for near to solid 
polyelectrolyte multilayer films and is well 
documented in the literature (Voinova 
1999, Voinova 2002). By assuming a 
known density, the relationship in 
Equation 5 was utilized. 
          
                     
       
                  
The mass per surface area is expressed in 
      , the thickness in  , and the 
density in       . For the polypeptide 
film layers, a density of             
was used (Höök 2001-II, Höök 2002). The 
data from Figure 6.1 fitted well for the 
third, fifth and seventh overtones, and 
Equation 5 was used to obtain the gradual 
build-up of mass during film assembly in 
Figure 6.2. The total thickness of three 
PLL/PLGA bilayers ended up at    
    . Figure 6.2 shows the rapid 
formation of the first bilayer and that 
steady state is quickly reached. However, 
polypeptide films are often referred to as 
“soft”, which is clearly observed in the 
subsequent bilayers. These layers take 
longer to reach steady state due to polymer 
reorganization after a fast initial 
adsorption. This behavior normally occurs 
after the formation of more than three bi-
layers (Lavalle 2002, Richert 2002, 
Halthur 2004-I). After film assembly, the 
samples were either dried in nitrogen gas, a 
procedure which should not affect the film 
thickness much, or kept in buffer in the 
QCM-D cells. 
 
 
 
 
 
Figure 6.2 Data from Figure 6.1 was fitted in a 
Voigt-based model to obtain the adsorbed mass, 
thus also the film thickness from Equation [5], for 
each consecutive layer. Each arrow indicates one 
adsorbed PLL/PLGA bilayer after rinsing with 
buffer (*). Three bilayers were assembled. 
 
6.2.3 PLL/PLGA nanofilm 
assembly studied with 
ellipsometry 
The thickness of the gold surface was 
measured by ellipsometry, and the raw data 
were fitted to the calculated data models in 
the TFCompanion software. A gold 
thickness of the substrate of 406 ± 7 Å was 
obtained, which agreed with the 410 Å 
specification from the supplier. The next 
step was the SAM surface on gold, which 
with a simple two layer model was 
approximated to 18 ± 2 Å. The deposited 
PLL/PLGA bilayers were modeled both as 
individual bilayers (SAM-Au-PLL/PLGA, 
SAM-Au-(PLL/PLGA)2, etc.) and as one 
“single” component (Au-SAM-
(PLL/PLGA)3). However, no models 
showed an appropriate fit to the measured 
data. Consolidating that the film not was 
rigid, air was included in both models. 
Incorporation of  10 vol% air gave a very 
good fit to the measured data when 
modeled as one single component. The dry 
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film thickness then resulted in 40 ± 3.4 Å. 
The mean square error for such a fit was 
0.011 for all measurements. Together with 
the information about the wet film 
thickness received from the QCM-D 
measurement, i.e. 10 nm, the results 
indicated that about 60 % of the wet film 
consisted of water.  Such water content is 
in agreement with literature values. 
However, in this study the PLL/PLGA film 
was assembled without the use of a primer. 
For the intended application, this is a 
considerable advantage because of the 
toxicity possessed by some of the 
commonly used primers.  
6.3 PLL/PLGA 2D nanofilms 
exposed to enzymes 
In the Theory section it was mentioned that 
the pH is elevated in chronic wounds 
(Dissemond 2003). Chemical hydrolysis of 
the film components at pH 7.4 can be 
assumed to be negligible, and only enzyme 
catalyzed degradation should occur. Also, 
the temperature was increased during 
degradation studies in the QCM-D to 
simulate skin temperature. The substrate 
specific V8 protease from S. aureus will 
also have an increased activity at this pH 
and temperature. An optimum film 
degradation time would be rather short if 
used as drug delivery barrier for infection. 
Thus, it would be of interest to have a 
release within 24 hours. 
6.3.1 Enzymatic degradation 
studied with QCM-D at skin 
temperature 
The Peltier plate was set to 32 
o
C. 
Important to note was that the system’s 
real temperature was 30.4 
o
C, since the 
Peltier plate proved not to be accurate at 
higher temperatures. However, since the 
skin temperature varies between 26 and 36 
o
C, the slight lowering of the temperature 
was considered to be acceptable for the 
intended application. As described in 
Chapter 3.5.2, the serine protease HNE 
(human neutrophil elastase) is naturally 
present in all wounds and destroys bacteria 
and damaged tissue as part of the healing 
cascade (Heck 1985, Korkmaz 2007). 
Hence, HNE was used as reference enzyme 
for simulation of non-infectious wounds. 
After injection of HNE, the QCM-D 
measurements revealed a slight increase in 
frequency, which can be related to the 
enzymatic adsorption to the film surface. 
This behavior is an initial step that can be 
seen in enzymatic degradation profiles; 
however, further measurements with HNE 
showed no increase in frequency, 
indicating no degradation of the 
(PLL/PLGA)3 film. The same procedure 
was repeated with the second reference 
enzyme, trypsin, and similar results were 
obtained as with HNE. Making sure the 
enzyme was active and attached to the 
substrate, trypsin was sequentially injected 
into the QCM-D chamber. This resulted in 
a stepwise increase in frequency, 
indicating progressive adsorption of 
trypsin. Both reference enzymes were 
initially added at low concentrations 
(1:100), similar to that present in a chronic 
wound; however, due to the high price of 
HNE, only trypsin was employed in higher 
concentrations. Addition of HNE resulted 
in an increase in film layer thickness of 
only a few nm, while the thickness of the 
adsorbed trypsin depended on the enzyme 
concentration injected into the 
measurement chamber. In both cases no 
enzyme catalyzed film degradation was 
observed over time. Studying the 
dissipation of the two different reference 
enzymes it was found that    increased 
slightly. The increase in film softness was 
probably due to entrapment of solvent 
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during and after adsorption; however, a 
partial degradation of peptide bonds, which 
would be expected to soften the film 
without fully degrading it, is also 
conceivable. The results described above 
were important for the intended 
application, especially since both enzymes 
carry a net negative charge at pH 7.4, 
which triggers adsorption to the positively 
charged PLGA. The situation was very 
different with the glutamyl endopeptidase, 
however. After injecting it into the 
measurement chamber the frequency 
increased almost immediately. This 
increase in    indicated loss in mass and 
hence degradation of the PLL/PLGA film. 
The graph shown in Figure 6.3 has stitched 
QTools files describing the desorption of 
film constituents at 30.4 
o
C. There is an 
obvious change in film properties with 
increased temperature, i.e. swelling. Thus, 
swelling of the PLL/PLGA nanofilm with 
increased temperature complicated the 
quantitative interpretation of the residual 
film thickness, if any. The first and 
strongly adsorbed PLL layer, or parts of it, 
may be thin and rigid and hence able to 
withstand or delay detachment (Bingen 
2008, Suchy 2011). Also, the swelling of 
the film with increased temperature may 
have concealed the remaining thickness 
after degradation. In order to assure that 
the presence of active enzymes was not the 
limiting factor more V8 was injected into 
the cell. This did not result in any further 
loss of material, however. The degradation 
profile is presented in Figure 6.4. The 
initial enzymatic adsorption step is seen as 
the first sharp peak (increased thickness), 
at the same time as the dissipation 
increased due to softening of the film. The 
increase in D is a sign of enzymatic 
activity due to cleavage of peptide bonds, 
i.e. softening of the film by allowing more 
solvent into the polymer network. In the 
second step a considerable amount of mass 
was lost. It is conceivable that the soft PLL 
and PLGA layers intermingled in 3D 
networks, exposing parts of the underlying 
polyelectrolyte layers. Such a 
rearrangement would enable new PLGA 
segments to be exposed as the proteolytic 
activity proceeds (see Chapters 3.1.1 and 
3.1.2). The desorption continued until 
reaching a plateau, which indicated 
complete, or near complete, degradation of 
the nanofilm. 
 
Figure 6.3 The graph describes the enzymatic 
degradation of the PLL/PLGA nanofilm. The film 
assembly is schematically presented by the dashed 
line (for details see Figure 6.2). The first arrow 
(left) indicates the addition of glutamyl 
endopeptidase (V8), which also is the start of the 
enzymatic degradation. Simultaneously, the 
temperature is changed from 22.5 to 30.4oC. The 
two arrows in the middle of the graph indicate 
addition of more V8, which was made to study 
whether the film could be further degraded and * 
indicates the final rinsing steps using Milli-Q 
water. 
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Figure 6.4 The enzymatic degradation profile. 
Substrate specific V8 enzyme was added (arrow) 
and adsorbed readily to the PLL/PLGA film 
surface, hence initially increasing the film 
thickness. The adsorption leads to proteolytic 
activity and degradation of the nanofilm. The graph 
does not include rinsing steps, see Figure 6.3. 
All the above measurements were 
performed with three bilayers and PLGA 
as the terminating layer, making sure that 
glutamic acid bonds were exposed to the 
V8 protease. Additionally, tests using V8 
on a film with PLL as the final layer was 
also investigated. The film consisted of 
three layers, i.e. 1.5 bilayers. The QCM 
measurements indicated that the negatively 
charged V8 enzyme adsorbed readily to the 
cationic PLL. However, no degradation 
was observed. This behavior was expected, 
since the bacterial enzyme is known to 
primarily cleave Glu-X bonds. Thus, for 
enzymatic degradation to occur, PLGA 
needs to be exposed to the enzyme. 
6.3.2 Enzymatic degradation 
studied with ellipsometry at 
ambient temperature 
The enzymatically treated (Au-SAM)-
(PLL/PLGA)3 samples were measured in 
the same way as the film assembly, but 
with addition of yet another layer with 10 
vol% air during the fit of the model. The 
temperature during the enzymatic exposure 
was set to 25 
o
C. As expected, trypsin 
adsorbed readily to the nanofilm, which 
resulted in a 5-fold increase of the film 
thickness at room temperature after 16 
hours as seen in Figure 6.5. V8 behaved 
differently under the set conditions. The 
(PLL/PLGA)3 thickness was more or less 
unchanged after addition of the V8 enzyme 
(Figure 6.5), despite the known attraction 
between the enzyme and the Glu-X bond. 
This implies that there is no interaction 
between V8 and the nanofilm at room 
temperature. This was an important piece 
of information, since it indicates that the 
nanofilm would stay intact and store 
covered antimicrobial substances until in 
contact with a wound at skin temperature. 
Although no direct difference in thickness 
was observed, it was concluded that the 
film surface exposed to V8 proteases had 
been subject to a slight proteolytic activity 
as evidenced by an increased surface 
roughness of the polypeptide film. 
However, the increased surface roughness 
(± 6 Å) disappeared with time, i.e. 24 to 48 
hours, when all measuring points ended up 
at the same value (± 1 Å). 
 
Figure 6.5 The dry nanofilm had a thickness of 4 
nm after three PLL/PLGA layers. The thickness 
increased significantly when exposed to trypsin 
(after 16 hours); however, the V8 enzyme had little 
effect on the layer thickness at ambient 
temperature. 
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6.4 Polyelectrolyte shells as 
barriers of 3D nanofilms 
The use of a polyelectrolyte film as a 
barrier carrying a drug can be realized 
when applied as a shell around the drug, or 
alternatively with the drug incorporated in 
the shell. In this section microspheres and 
microcapsules have been assembled with 
shells responding to different bacterial 
proteases. 
6.4.1 o/w emulsion based 
microspheres 
The idea of microspheres with an oily core 
originated when handling the easily 
hydrolysable betaine ester; however, it was 
also seen as an opportunity to incorporate 
hydrophobic drugs in the oil phase. The 
betaine ester was only soluble in a polar oil 
(glyceryl trioctanoate (GTO)). The o/w 
emulsion with a betaine ester/GTO core 
and a polypeptide shell produced rather 
stable emulsions. As for visualizing the 
event, the model drug Nile Red was 
dissolved in a GTO/corn oil mixture, since 
pure GTO in combination with Nile Red 
produced an emulsion with poor stability. 
For both types of spheres, PLGA was used 
as emulsifier, followed by the LbL 
assembly with oppositely charged PLL, 
and so on, until up to 5 layers were 
assembled. For each layer, the ζ-potential 
was measured, see Figure 6.6. The wash 
step was tedious and gave a low yield, 
particularly with pure GTO and betaine 
ester as the core, since the density of water 
and GTO are very similar. High speed 
centrifugation, sufficient to separate the 
droplets from the water phase, but not 
violent enough to rupture them, seemed to 
be the best solution. Filtration was 
investigated, but it resulted in clogged 
membranes and ruptured spheres. 
(PLGA/PLL)2.5 microspheres with a 
diameter of 1-3 μm can be seen in Figure 
6.7. To improve the o/w emulsion stability, 
the polypeptides were crosslinked with 
EDC and sulfo-NHS without considerable 
change in sphere size. The concentration of 
both agents were varied and 200 mM EDC 
and 50 mM sulfo-NHS were found to be 
optimal for good stability over time. 
 
 
 
Figure 6.6 ζ-Potential of the microspheres after 
stepwise adsorption of PLGA and PLL. Error bars 
represent standard deviations calculated from three 
experiments.  
 
 
 
 
Figure 6.7 Left: CLSM picture of microspheres. 
The red color depicts the core loaded with Nile red 
dissolved in a 1:1 mixture of GTO and corn oil. The 
nanofilm acting as shell consists of 2.5 crosslinked 
bilayers. Right: A light microscope picture 
revealing the real amount of microspheres in the 
same frame. 
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The emulsions with crosslinked shells 
showed very little separation after more 
than one year on a magnetic stirrer. 
However, when the microspheres were 
placed in an ESEM for evaluation at 1 
o
C 
and approximately 657 Pa, the spheres 
resisted the “harsh” conditions until the 
water had fully evaporated from the 
polypeptide shell, a process which first 
flattened and then ruptured the spheres (see 
Figure 6.8). Prior to the evaporation, the 
picture quality was very poor. 
 
Figure 6.8 The ESEM picture shows dried o/w 
microspheres with a PLGA/PLL-shell and are 
circled for better visibility. Focusing the beam 
destroyed the spheres, which made it difficult to 
receive high resolution pictures. The drying process 
partly flattened the microspheres, which made them 
look smaller in their dry state than in solution. 
(Anna Jansson, Applied Physics, Chalmers 
University of Technology) 
 
6.4.2 Microspheres exposed 
to enzymes studied with 
CLSM and UV/vis 
The enzyme solutions were added to the 
microsphere solutions for 16 hours at 32 
o
C 
in concentrations of 1:8 for HNE and 1:50 
for V8 to investigate the proteolytic 
degradation on crosslinked spheres. The 
HNE concentration was a test for stability 
in an extreme situation and the V8 
concentration was within the range of an 
infected chronic wound. As a first step, 
CLSM was used to study the effect of the 
proteases.  
HNE had an effect on aggregation of the 
spheres (Figure 6.); however, the 
fluorescent probe was still present in the 
oily core. Thus, no release was discovered 
when exposed to HNE. As for the samples 
with added V8, no microspheres were 
anywhere to be found. The search led to 
the edge of the sample droplet, where the 
release of Nile Red was driven onto the 
glass surface, avoiding the hydrophilic 
buffer, see Figure 6.10. 
 
Figure 6.9 Microspheres after addition of HNE at 
32 oC for 16 hours. The microspheres are intact, 
although slightly more aggregated, particularly 
around the piece of dust to the left. 
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Figure 6.10 After adding V8 protease, the 
microspheres degraded leaving only a few 
polymeric aggregates in solution. The hydrophobic 
Nile red was either found in these aggregates or 
adhering to the glass surface (left). 
To further support the idea about release of 
Nile Red from the microspheres after 
exposure to V8, isopropyl myristate (IPM) 
was chosen as release medium and UV 
spectroscopy as detection method. Nile 
Red has very low solubility in water (1 
μg/mL) (Castro 2005) and would not give 
reliable release results. For the standard 
curve, see Paper III. A rapid release during 
stirring was found at 32 
o
C and only within 
a couple of hours a maximum had been 
reached at 0.13 mM, see Figure 6.11. This 
concentration is equivalent to 41.4 μg/mL 
in the microsphere suspension, which is a 
relevant drug dosage. Also a higher 
concentration could be achieved by 
increasing the microsphere concentration 
in the dispersion. However, since the 
concentration after 24 hours was slightly 
lower, 0.10 mM, either a gradient may 
have created the maximum, or the stirring 
was too weak to prevent Nile Red from 
adsorbing to surrounding hydrophobic 
surfaces. 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 Release curve of Nile red in IPM 
during 24 h. 
 
6.4.3 PAH/PLGA assembly 
with CaCO3 as sacrificial 
template 
The porous CaCO3 template had a size of 
approximately 3 μm with a pore size of 
below 10 nm (personal communication, 
Plasmachem GmbH). CaCO3 spheres in 
the range of 4-6 μm usually have pores in 
the range of 20-60 nm (Volodkin 2004). 
The pores can either be loaded with active 
substance prior to the LbL assembly or by 
postloading. Due to the bulkiness of one of 
the drugs and due to aggregation issues of 
the templates in the absence of a 
polyelectrolyte layer, the last approach was 
used. The CaCO3 spheres were negatively 
charged at pH 7 (-40 mV); however, both 
anionic and cationic polyelectrolytes could 
be deposited onto the templates (personal 
communication with supplier). In order to 
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achieve good coverage of the pores, PAH, 
which is a high molecular weight 
polyelectrolyte, was chosen for the initial 
layer. High molecular weight 
polysaccharides had previously been used 
for the same purpose (Szarpak 2008). 
Although a high MW PAH was used as the 
first layer, the PLL/PLGA system did not 
seem to provide enough coverage for the 
subsequent layers, and severe aggregation 
occurred after 2 assembled bilayers. Most 
likely the molecular weights of the 
combined polypeptides were too small. 
Hence, PAH was used as the cationic 
polyelectrolyte throughout the LbL 
assembly. PLGA was maintained as the 
negatively charged polyelectrolyte, due to 
the specificity of the bacterial protease. It 
has been reported that capsules should be 
assembled with maximum 5 bilayers to 
avoid severe aggregation (Szarpak 2010), 
which also was seen in this study. Hence, 
the capsules were assembled with 3 
bilayers, (PAH/PLGA)3, and the ζ-
potential is presented in Figure 6.12. A 
light microscope was used to keep track on 
aggregation and to assess the size of the 
capsules.  
 
Figure 6.12 The ζ-potential for each PAH- and 
PLGA-layer. Three bilayers were assembled, 
(PAH/PLGA)3. 
Crosslinking the film by addition of EDC 
and sulfo-NHS led to aggregation. After 
dissolving the template core by addition of 
GDL, the light microscopy and ESEM 
pictures showed finely dispersed capsules. 
A tentative explanation to the aggregation 
is a change in surface charge on the 
microcapsules after crosslinking. Some 
amino groups and carboxyl groups have 
been transformed into amide bonds, which 
mean that the concentration of charged 
functional groups on the capsule surface 
has decreased. This may lead to reduced 
electrostatic stabilization of the dispersion. 
However, the dissolution of the template 
led to a high concentration of Ca
2+
 ions, 
resulting in the increase of the electrostatic 
repulsion due to a screening effect. Also, 
throughout the work, it was seen that the 
microcapsules readily aggregated at very 
low or very high ionic strengths, while a 
salt concentration of 0.15-0.5 M NaCl 
maintained dispersed capsules. The 
removal of the core could be monitored by 
the eye, since the suspension turned 
transparent after GDL addition. This was 
also confirmed by SEM and one 
representative picture can be seen in the 
top of Figure 6.13. In Figure 6.14 a SEM 
close-up of a whole microcapsule is seen, 
with its shell interacting with the rest of the 
clusters’ capsule shells in vacuum. This 
interaction was possibly a reason to why 
many capsules in clusters did not rupture 
(in vacuum) while single capsules and a 
few on the outer parts of the clusters did. 
Adding EDC at 100 or 200 mM to 
PAH/PLGA capsules did not result in any 
visible changes when zooming into the 
clusters. However, there were many larger 
clusters, and thus more complete capsules, 
when EDC had been added in a 
concentration of 200 mM. 
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Figure 6.13 SEM picture of (PAH/PLGA)3 
microcapsules. The harsh environment ruptured 
single capsules and capsules on the surface of the 
cluster. In the top of the micrograph, one of the 
capsules with a damaged shell visualizes the hollow 
core. 
 
Figure 6.14 A SEM image close-up of a 
microcapsule. It can also be seen that the shells in 
the cluster of capsules interacted during drying in 
the vacuum, possibly contributing to them not 
rupturing. 
 
6.4.4 HA/PLL assembly with 
CaCO3 as sacrifical template 
The HA/PLL microcapsules were 
assembled in the same manner as in 
Chapter 6.4.3. The high viscosity of HA 
required some small changes in the 
procedure, which are described in the 
Experimental section. The choice of 
hyaluronic acid as anionic polyelectrolyte 
was not only due to its non-toxic 
properties, but also to its availability in 
high molecular weights, which is important 
for good coverage of the CaCO3 pores. The 
ζ-potential for the HA/PLL film build-up is 
presented in Figure 6.15. HA is a sticky 
macromolecule with good wetting ability, 
which allowed the (HA/PLL)3 shell to 
swell in solution (Knepper 1995, Nitzan 
2001, Scherge 2001). Hence, the 
crosslinked and hollow microcapsule 
average size ended up between 3 and 5 μm 
in diameter. Again, it was obvious that the 
core became hollow after addition of GDL 
as the solution changed from milky to 
transparent. This was also visualized with 
SEM, see Figure 6.16, which shows a 
sample that has been crosslinked with 100 
mM EDC, a concentration which only gave 
a few capsules that were more or less intact 
(in vacuum).  
 
Figure 6.15 The ζ-potential for each HA- and PLL-
layer. Three bilayers were assembled, (HA/PLL)3. 
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Figure 6.16 SEM image of a crosslinked (100 mM 
EDC/50 mM Sulfo-NHS) and hollow (HA/PLL)3 
that  ruptured in vacuum. Most capsules had 
ruptured in vacuum. 
By increasing the EDC concentration the 
shell remained intact, but the capsule 
instead collapsed in the center, see Figure 
6.17. 
 
 
Figure 6.17 SEM image of crosslinked (200 mM 
EDC/50 mM Sulfo-NHS) (HA/PLL)3 capsules. The 
high EDC concentration gives an intact shell; 
however, the top has collapsed.  
Similar to the PAH/PLGA capsules the 
polysaccharide containing capsules did not 
cope with vacuum. More or less all 
HA/PLL capsules collapsed or ruptured in 
vacuum; however, as air-dried PAH/PLGA 
and HA/PLL capsules were complete after 
air-drying (studied with light and 
fluorescence microscopy), the ruptures 
seemed to be related to the harsh 
conditions under the preparation of the 
SEM samples and in the SEM.  
6.4.5 Loading of PAH/PLGA 
and HA/PLL microcapsules  
The loading of the microcapsules with 
FITC-dextran is described in Paper IV-V 
and in the Experimental section. FITC-
dextran is used as a model drug to show 
proof of concept in loading the two capsule 
types with an available and equitable 
probe. The PAH/PLGA capsules ended up 
with a fluorescence about twice as high as 
the background intensity, which was 
unwashed and still contained the probe 
solution. Similarly, the HA/PLL capsules 
resulted in an intensity 1.5 times higher 
than the background (see Paper V). These 
results indicated successful FITC-dextran 
loading of both capsule types; however, the 
loading of the HA/PLL capsules was time-
dependent. Instead of 30 minutes loading 
time as for PAH/PLGA capsules, several 
hours were needed for the polysaccharide 
containing capsules. This slow step was 
possibly related to the very large anionic 
HA molecule creating an obstacle for 
penetration through the film for the anionic 
probe. On the contrary, when drug-like 
probes were used, i.e. Rhodamine Green 
and Vancomycin BODIPY, both capsule 
types could easily be discovered in the 
microscope due to a stronger intensity in 
the loaded capsules compared to the 
background. After loading the actual drugs, 
PHMB and Vancomycin, the suspensions 
were put through a syringe filter. By doing 
so, the drug content of the microcapsules 
could be indirectly estimated by NMR by 
measuring the remaining drug 
concentration in the surrounding solution. 
As was indicated with microscopy for the 
capsules with the drug-like probes, a large 
quantity of drug had disappeared from the 
solution. 80 % of PHMB or 50 % of 
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Vancomycin were present in the 
PAH/PLGA capsule structure, while the 
HA/PLL capsules contained 80 % PHMB 
and 20-40 % Vancomycin. Continuing 
measurements with NMR on the washed 
capsule suspensions indicated that PHMB 
and Vancomycin were mainly immobilized 
in the capsule shell. Additionally, 
independent of which drug that was used, 
about 1 % of drug adsorbed to the outer 
capsule wall was in equilibrium with the 
surrounding solution, see Table 6.1.  
 
Microcapsule 
and drug 
Pure solution: 
Encapsulated 
drug conc 
[drug in 
equilibrium] 
(mg/mL) 
AM test 
samples 
(dilution): 
Encapsulated 
drug conc 
[drug in 
equilibrium] 
(mg/L) 
(HA/PLL)3 + 
PHMB 
24 [0.15] 12 [0.075] 
(HA/PLL)3 + 
VAN 
0.60 [0.015] 0.30 [0.0075] 
(PAH/PLGA)3 
+ PHMB 
24 [0.15] 12 [0.075] 
(PAH/PLGA)3 
+ VAN 
0.70 [0.015] 0.35 [0.0075] 
Table 6.1 Concentrations of encapsulated PHMB 
and Vancomycin (VAN) and the surrounding drug 
in equilibrium in brackets as determined with NMR. 
The right column displays the actual concentrations 
during the antimicrobial tests after dilution with 
bacteria in SWF. (Note: The HA/PLL microcapsule 
batch with VAN in the table had a loading capacity 
of 40 %.) 
6.4.6 PAH/PLGA and 
HA/PLL nanofilms exposed 
to enzymes 
CLSM, light microscopy and NMR were 
the techniques used to evaluate the effect 
of enzymatic exposure of the 
microcapsules. Particularly CLSM was 
used to visualize and measure any change 
in microcapsule structure and intensity 
before and after enzymatic exposure. 
Additionally, with FITC-dextran as the 
fluorescent model drug it was possible to 
detect whether it was released or if it 
remained in the capsule after exposure to 
proteolytic enzymes. Capsules exposed to 
the human wound enzyme, HNE, did 
neither rupture the capsule structure nor 
release the probe, see Figure 6.18. 
Unfortunately, the picture quality for the 
HA/PLL images ended up poor due to 
problems with the zoom, hence a 
microscopy image of the same sample was 
taken using a light microscope (Figure 6.18 
(c)). Figures 6.19 (a) and (b) show the 
PAH/PLGA capsules loaded with FITC-
dextran before and after addition of V8 
protease at 32 
o
C. Figure 6.20 (a) and (b) 
describe the HA/PLL capsules before and 
after addition of Protease IV. Both capsule 
types exposed to their respective bacterial 
proteases released all the anionic probe; 
however, since the samples were 
unpurified, a small amount of probe was 
still found in the structures when 
measuring the intensity before and after 
enzymatic exposure (Figure 6.21). In short, 
in a clean environment V8 degraded the 
Glu-X bonds and Protease IV cleaved Lys-
X bonds, thus exposing the anionic probe 
successfully. Since V8 and Protease IV are 
bacterial virulence factors, the initial 
results indicated that a release related to 
the degree of infection can be achieved. 
Hence all results above were in accordance 
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with the results presented in Chapter 6.3.1. 
The FITC-dextran signal was unfortunately 
not strong enough for investigation of the 
release by NMR but both PHMB and 
Vancomycin were easily detectable.  
 
Figure 6.18 CLSM images after exposure to HNE. 
(a) PAH/PLGA capsules are still intact with the 
probe present in the capsules. (b) HA/PLL capsule 
images ended up poor; however, (c) shows a light 
microscopy image of the sample. Together, (b) and 
(c) indicate that the capsules are intact and that the 
probe is present in the capsules. HNE did 
contribute to a slight aggregation of HA/PLL 
capsules. 
 
 
 
Figure 6.19 PAH/PLL microcapsules with FITC-
dextran in (a) and after exposure to V8 in (b). 
As previously described, both PHMB and 
Vancomycin were mainly immobilized in 
the capsule structure. Despite the efforts of 
either exposing the loaded capsules to the 
bacterial proteases in a shaker at 32 
o
C or 
adding the proteases straight into the NMR 
b 
c 
a 
b 
a 
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tube at 32 
o
C before the measurement, all 
samples ended up with drugs still bound to 
the degraded structures. However, light 
microscopy and CLSM images confirmed 
the rupture of both the PAH/PLGA and the 
HA/PLL microcapsules after exposure to 
V8 and Protease IV, respectively. 
 
Figure 6.20 Image (a) shows a single HA/PLL 
capsule loaded with FITC-dextran. In (b) the 
exposure to Protease IV has degraded the capsule 
structures and the probe is released. 
 
 
 
 
 
Figure 6.21 The intensity was measured in the 
CLSM images. Relative intensity (with the 
background (external) intensity set to 1) for the two 
types of microcapsules. The (PAH/PLL)3 
microcapsules went from 1.8 to 0.4 after exposure 
to V8. The (HA/PLL)3 microcapsules went from 1.5 
to 0.6 after exposure to Protease IV (named rLys-C 
in the figure).  
 
6.4.1 Antimicrobial efficacy 
of microcapsules 
A buffer solution is a much different 
environment than a wound fluid. Instead, a 
protein rich solution called simulated 
wound fluid, SWF, can be used. Such an 
environment is much closer to reality, but 
the chemical analysis of drugs and their 
release in SWF is intricate. However, SWF 
is also used as a nutritious medium for 
bacteria, allowing the antimicrobial (AM) 
effect of the drug release to be investigated 
by studying the survival of the 
microorganisms. The solution’s protein 
content will act as a physical hinder 
between the enzymes and the capsules as 
well as the drugs and the bacteria, resulting 
in a much tougher test than in a buffer 
solution. The microorganisms chosen were 
two virulent strains originating from 
wounds, i.e. Staphylococcus aureus and 
Pseudomonas aeruginosa. Both capsule 
types were either empty or loaded with 
a 
b 
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PHMB or Vancomycin. Also, as described 
earlier, 1 % of the loaded drugs were in 
equilibrium with its surroundings. Hence, 
samples containing free PHMB or 
Vancomycine in buffer were also tested on 
the two bacteria. In the current AM study a 
successful killing effect was related to a 
log-reduction of 4, i.e. to 10
2
 in bacterial 
count, which is the same as the detection 
limit for the current method. Such a 
decrease normally assures that the 
infection is eliminated and that no 
regrowth of the treated colonies will occur. 
As can be seen in Figures 6.22 and 6.23, 
the free roaming PHMB had an immediate 
killing effect on both S. aureus and P. 
aeruginosa, and the bacterial count was 
lowered to below the detection limit only 
after 3 hours. Vancomycin had as expected 
no effect on P. aeruginosa. On S. aureus it 
had a slight effect after 3 hours and an 
insufficient killing effect after 24 hours 
(10
3
). With these results it may have 
seemed unnecessary to test the loaded 
microcapsules on bacteria. However, an 
environment with immobilized drugs in the 
microcapsules is rather different from one 
with freely diffusing drug molecules and 
the outcome of the AM test with the 
microcapsule dispersion is therefore not 
easy to predict.  
When the PAH/PLL capsules containing 
the bulky antibiotic substance was added to 
S. aureus, the AM effect was small after 3 
hours, but landed on a count below the 
detection level after 24 hours. Thus, in this 
form the microcapsule allowed for a 
successful killing effect compared to the 
result with the pure Vancomycin solution, 
most probably due to a burst release effect 
as a result of V8’s proteolytic activity. This 
also confirms that the capsule environment 
is very different from that of the free drug 
in solution. Interestingly, Vancomycin in 
HA/PLL capsules also killed P. aeruginosa 
within 24 hours. This was somewhat 
unexpected considering that P. aeruginosa 
is a Gram-negative species. As mentioned 
in the Theory section, Vancomycin is 
generally not active against Gram-negative 
bacteria, which also was seen with free 
Vancomycin in solution. Surface active 
agents or acids can increase the 
permeability of the bacterial membrane 
and hence work as a synergist and increase 
the antimicrobial effect of an antibiotic 
substance (Ayres 1999). Also, recent 
studies have shown an enhanced 
antimicrobial effect due to stronger 
interaction with the bacterial membrane on 
P. aeruginosa using Vancomycin, which 
was adsorbed or covalently bound to a 
carrier particle or molecule (Kell 2008, 
Gurunathan 2014). In the present 
communication we did not study this 
surprising mechanism further, although 
there was obviously an element of 
synergistic nature increasing the efficacy 
of Vancomycin against the Gram-negative 
species. The enzymatic degradation of the 
nanofilm by Protease IV may have created 
moieties working as carriers or 
permeabilizers responsible for the 
synergistic effect.  
When loading the microcapsules with 
PHMB, a less bulky molecule than the 
antibiotic discussed above, both 
microcapsule formulations showed no 
effect on any bacterium after 3 hours, but a 
successful killing effect after 24 hours. 
Such results also indicate that the capsule 
suspensions should not be compared to a 
drug without a carrier. The strong 
antimicrobial effect of free PHMB in 
solution is believed to be related to the 
relatively high content of free PHMB in 
solution. Contrary to Vancomcyin loaded 
capsules, the PHMB molecules 
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surrounding the microcapsules could not 
be disregarded when evaluating the 
antimicrobial effect related to degradation 
of the microcapsules. 
To investigate the specificity of the 
bacterial proteases and the nanofilm shells, 
the microcapsule suspension was added to 
the “opposite” bacterium, i.e. PAH/PLGA 
to S. aureus and HA/PLL to P. aeruginosa. 
The microcapsules were loaded with 
Vancomycin instead of PHMB, due to the 
inability of disregarding the effect of the 
latter drug in solution. The P. aeruginosa 
was unaffected by the PAH/PLL capsules, 
which was no surprise because of the 
properties of the drug but also due to the 
film composition. S. aureus, on the other 
hand, was only slightly affected by the 
HA/PLL/Vancomycin capsules. This result 
seems primarily to be due to an inability of 
S. aureus to degrade the nanofilm. The 
inhibition in growth and the slight decrease 
was probably due to the drug present in 
solution.  
Figure 6.22 Antimicrobial efficacy against 
Pseudomonas aeruginosa of free Vancomycin and 
PHMB and of these antimicrobials loaded into 
capsules. Simulated wound fluid was used as 
medium. 
 
Contrary to FITC-dextran being released 
from the degraded capsule structures 
(CLSM), the NMR results for the drugs 
revealed no release of PHMB or 
Vancomycin. It was hence clear that the 
majority of the actives had adsorbed to the 
nanofilm structure, and stayed immobilized 
after the proteolytic activity. Also, the drug 
present in solution was in equilibrium with 
the surfaces, not roaming free in solution. 
This means that there are different 
possibilities to account for the 
bioavailability of the drugs. The first 
option is that the drugs are efficient 
antimicrobials in spite of the fact that they 
are bound to the degraded polymer. The 
second option is that the adsorbed drugs 
are in equilibrium with free drug molecules 
in solution. We favor the second option, 
since for both drugs the NMR studies 
revealed a small but constant amount in the 
surrounding buffer after washing the 
capsule suspension. Such a system would 
allow for a burst release of drugs if 
exposed to large areas of bacterial cell 
walls, proteins, etc.  
The post-loading of drugs into the 
microcapsules was obviously a 
straightforward experimental procedure; 
however, particularly for PHMB the 
method needs to be improved. Adding 
polyelectrolyte layers after drug loading, or 
preloading the templates before LbL 
assembly are examples of possible ways to 
improve the procedure. For Vancomycin 
the PAH/PLGA capsules increased the AM 
effect on S. aureus, probably due to burst 
release since the AM effect is 
concentration dependent. The surprising 
AM effect of Vancomycin on P. 
aeruginosa is yet to be explained. With 
recent studies in mind it seems likely that a 
synergy between Vancomycin and 
products from the proteolytic degradation 
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of the nanofilm is responsible for the 
successful killing effect.  
 
Figure 6.23 Antimicrobial efficacy against 
Staphylococcus aureus of free Vancomycin and 
PHMB and of these antimicrobials loaded into 
capsules. Simulated wound fluid was used as 
medium. 
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7 CONCLUDING 
REMARKS 
By using existing knowledge about drug 
release, the environment where the drug is 
released and, in the current work, which 
microorganisms that can contribute to 
release, smart release platforms can be 
assembled. Two bacterial proteases were 
identified in this project, V8 from S. 
aureus and Protease IV from P. 
aeruginosa. The two enzymes were chosen 
since they possess the following three 
characteristics: (1) They are direct or 
indirect virulence factors; in other words, 
they exist in pathogens and create disease. 
(2) They continuously contribute to the 
survival of the pathogens by providing 
nutrients through cleaving host tissue. (3) 
They have a high degree of substrate 
specificity  (which is taken advantage of in 
peptide mapping). These three 
characteristics contributed to the idea of 
creating a nanofilm as a drug barrier, 
which would degrade only in case of 
bacterial infection. Such a film would be 
degraded when a substrate specific 
virulence factor has reached a certain 
concentration indicating infection. Hence a 
smart release system that combats 
infection, particularly in chronic wounds 
and only when the drug is needed, could be 
assembled. V8 is specific for Glu-X bonds, 
while Protease IV is specific for Lys-X 
bonds, two peptide bonds that are readily 
found in polypeptides. Thus, a Glu-X rich 
bond was created in a 2D format studied 
with QCM-D, with PLGA as the anionic 
component and as the terminating layer. 
HNE and trypsin were used as reference 
enzymes; as expected, neither of these 
degraded the structure, while V8 did. This 
concept was also applied in “3D” as o/w 
emulsion microspheres and as template 
assisted assembled (hollow) 
microcapsules. In those forms, a drug 
could be incorporated into the structure.  
As for Protease IV, a lysine-rich film was 
assembled in the shape of microcapsules. 
Initially, an anionic probe was used as 
model drug. If the nanofilms were 
crosslinked, their stability against human 
wound enzymes increased and only a slight 
aggregation without drug release was 
discovered. Exposing the same types of 
microcapsules to the respective protease, 
the structures were degraded and the model 
drug released. When loading the 
microcapsules with a rather large amount 
of an antimicrobial drug, the result was 
different. The cationic PHMB and the 
neutral and bulky Vancomycin were 
immobilized in the film structures. Using 
NMR, it was found that before and after 
degradation of the microcapsules, the 
amount of drug in the surrounding solution 
was constant; however, microscopy 
showed degraded polymeric parts of 
former capsules. By exposing the 
microcapsules to bacteria in SWF, the 
antimicrobial killing effect was evident. 
For PHMB loaded microcapsules, both S. 
aureus and P. aeruginosa were eliminated 
after the specific degradation of the 
nanofilm shells. However, due to the 
strong AM effect of the drug, the free drug 
in the surrounding solution probably also 
contributed to the antimicrobial effect. On 
the other hand, for Vancomycin loaded 
microcapsules, the AM killing effect could 
be related to the specific degradation of V8 
in S. aureus and Protease IV in P. 
aeruginosa. However, the antimicrobial 
effect of Vancomycin on the Gram-
negative species was unexpected, but could 
possibly be related to synergistic effects 
between the degraded capsule constituents 
and the drug.  
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This work involves the assembly of smart 
delivery systems against infections caused 
by S. aureus and P. aeruginosa. By using 
the bacteria’s own survival mechanisms, it 
was possible to start building a platform 
for smart drug release that combats 
infection.  
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ACRONYMS 
BODIPY  4,4-difluoro-4-nora-3a,4a-diaza-s-indecene 
CLSM  confocal laser scanning microscopy 
EDC  N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
ESEM  environmental scanning electron microscopy 
FITC-dextran Fluorescein isothiocyanate-dextran 
GDL  gluconoc delta-lactone (D-gluconic acid δ-lactone) 
GTO  glyceryl trioctanoate 
HA  hyaluronic acid 
HNE  human neutrophil elastase 
MES  2-(N-morpholino) ethanesulfonic acid sodium salt 
NMR  nuclear magnetic resonance 
o/w  oil in water (emulsion) 
PAH  poly allylamine hydrochloride 
PHMB  polyhexamethylene biguanide 
PLGA  poly-L-glutamic acid 
PLL  poly-L-lysine 
QCM-D  quartz crystal microbalance with dissipation monitoring 
SAM  self-assembled monolayer 
SEM  scanning electron microscopy 
Sulfo-NHS   N-hydroxysulfosuccinimide sodium salt  
V8  glutamyl endopeptidase 
VAN  Vancomycin 
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